T-CMVA
MCID: ALP042
MIFTS: 66

Alpha/beta T-Cell Lymphopenia with Gamma/delta T-Cell Expansion, Severe Cytomegalovirus Infection, and Autoimmunity (T-CMVA)

Categories: Blood diseases, Genetic diseases, Immune diseases, Rare diseases

Aliases & Classifications for Alpha/beta T-Cell Lymphopenia with Gamma/delta T-Cell Expansion,...

MalaCards integrated aliases for Alpha/beta T-Cell Lymphopenia with Gamma/delta T-Cell Expansion, Severe Cytomegalovirus Infection, and Autoimmunity:

Name: Alpha/beta T-Cell Lymphopenia with Gamma/delta T-Cell Expansion, Severe Cytomegalovirus Infection, and Autoimmunity 56 52 29 13 6 39
Combined Immunodeficiency with Expansion of Gamma Delta T Cells 52 58
Combined Immunodeficiency Due to Partial Rag1 Deficiency 52 58
Cid with Expansion of Gamma Delta T Cells 52 58
Cid Due to Partial Rag1 Deficiency 52 58
Alpha/beta T-Cell Lymphopenia, with Gamma/delta T-Cell Expansion, Severe Cytomegalovirus Infection and Autoimmunity 73
Autoimmune Diseases 71
Autoimmune State 71
Autoimmunity 43
T-Cmva 73

Characteristics:

Orphanet epidemiological data:

58
combined immunodeficiency due to partial rag1 deficiency
Inheritance: Autosomal recessive; Prevalence: <1/1000000 (Worldwide); Age of onset: Infancy,Neonatal; Age of death: early childhood;

Classifications:

Orphanet: 58  
Rare immunological diseases


External Ids:

OMIM 56 609889
ICD10 via Orphanet 33 D81.8
UMLS via Orphanet 72 C1835931
Orphanet 58 ORPHA231154
MedGen 41 C1835931
UMLS 71 C0004364 C0004368

Summaries for Alpha/beta T-Cell Lymphopenia with Gamma/delta T-Cell Expansion,...

NIH Rare Diseases : 52 The following summary is from Orphanet , a European reference portal for information on rare diseases and orphan drugs. Orpha Number: 231154 Definition Combined immunodeficiency due to partial RAG1 deficiency is a form of combined T and B cell immunodeficiency (CID; see this term) characterized by severe and persistent cytomegalovirus (CMV) infection and autoimmune cytopenia. Epidemiology Prevalence is unknown. To date, 9 cases have been reported. Clinical description Patients present before the age of one year with severe disseminated CMV infection, which can manifest with fever and splenomegaly, and recurrent and severe co-infections including sepsis and pneumonitis. Autoimmune cytopenia also occurs and can include autoimmune hemolytic anemia (see these terms) or neutropenia. Etiology SCID due to partial RAG1 deficiency is caused by hypomorphic mutation in the RAG1 gene (11p13). This results in oligoclonal expansion of T cell receptor (TCR) gamma-delta T cells and TCR alpha-beta T cell lymphopenia, although total lymphocyte counts are normal, in combination with CMV infection and autoimmunity. Diagnostic methods Diagnosis is based on clinical evaluation, immunological investigation, including lymphocyte subset phenotyping, lymphocyte proliferation to mitogen stimulation, immunoglobulin levels and antibody response to vaccine antigens, and genetic confirmation. Differential diagnosis Differential diagnoses include other combined immunodeficiencies. Antenatal diagnosis Prenatal diagnosis can be performed in families where there is a family history and in which the genetic mutation has been identified. Genetic counseling Transmission is autosomal recessive . Management and treatment Treatment involves antiviral treatment and management of recurrent infections. Bone marrow transplant has been attempted but may result in graft versus host disease (GVHD; see this term) associated with reactivation of CMV disease. Patients should be treated in centers with experience of transplanting complex primary immunodeficiencies. Prognosis The majority of patients reported to date have died within the first few years of life. Visit the Orphanet disease page for more resources.

MalaCards based summary : Alpha/beta T-Cell Lymphopenia with Gamma/delta T-Cell Expansion, Severe Cytomegalovirus Infection, and Autoimmunity, also known as combined immunodeficiency with expansion of gamma delta t cells, is related to autoimmune polyendocrine syndrome, type i, with or without reversible metaphyseal dysplasia and autoimmune addison disease. An important gene associated with Alpha/beta T-Cell Lymphopenia with Gamma/delta T-Cell Expansion, Severe Cytomegalovirus Infection, and Autoimmunity is RAG1 (Recombination Activating 1), and among its related pathways/superpathways are T cell receptor signaling pathway and Th17 cell differentiation. The drugs Ledipasvir and Sofosbuvir have been mentioned in the context of this disorder. Affiliated tissues include t cells, thyroid and b cells, and related phenotypes are splenomegaly and sepsis

UniProtKB/Swiss-Prot : 73 Alpha/beta T-cell lymphopenia, with gamma/delta T-cell expansion, severe cytomegalovirus infection and autoimmunity: An immunological disorder characterized by oligoclonal expansion of TCR gamma/delta T-cells, TCR alpha/beta T-cell lymphopenia, severe, disseminated cytomegalovirus infection and autoimmune cytopenia.

More information from OMIM: 609889

Related Diseases for Alpha/beta T-Cell Lymphopenia with Gamma/delta T-Cell Expansion,...

Diseases related to Alpha/beta T-Cell Lymphopenia with Gamma/delta T-Cell Expansion, Severe Cytomegalovirus Infection, and Autoimmunity via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 2854, show less)
# Related Disease Score Top Affiliating Genes
1 autoimmune polyendocrine syndrome, type i, with or without reversible metaphyseal dysplasia 34.4 GAD2 GAD1 AIRE
2 autoimmune addison disease 34.4 CTLA4 AIRE
3 anemia, autoimmune hemolytic 33.8 TNFSF13B FOXP3 CTLA4
4 systemic autoimmune disease 33.7 IL17A AIRE
5 vitiligo-associated multiple autoimmune disease susceptibility 1 33.7 TPO TG PTPN22 CTLA4 AIRE
6 autoimmune enteropathy 33.5 IL17A FOXP3
7 autoimmune disease of urogenital tract 33.4 IL17A IL10 CTLA4
8 autoimmune polyendocrine syndrome type 1 33.4 IL17A FOXP3 AIRE
9 autoimmune polyendocrine syndrome, type ii 33.3 PTPN22 INS GAD2 GAD1 AIRE
10 autoimmune uveitis 33.3 IL17A IL10 IFNG
11 autoimmune lymphoproliferative syndrome 33.2 IL10 FOXP3 CTLA4 AIRE
12 hashimoto encephalopathy 33.2 TSHR TPO
13 autoimmune hepatitis 33.1 TPO IL10 FOXP3 CTLA4 AIRE
14 autoimmune disease of cardiovascular system 32.8 FOXP3 CTLA4
15 hypoadrenocorticism, familial 32.8 TPO TG PTPN22 CTLA4 AIRE
16 autoimmune gastritis 32.7 IL10 IFNG FOXP3
17 autoimmune pancreatitis 32.5 TNFSF13B IL17A IL10 FOXP3 CTLA4
18 autoimmune disease of eyes, ear, nose and throat 32.5 IL17A IL10 FOXP3 CTLA4
19 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 32.5 IL17A IL10 FOXP3 CTLA4 AIRE
20 autoimmune disease of blood 32.4 TNFSF13B IL10 FOXP3 CTLA4
21 limbic encephalitis 32.4 TPO GAD2 GAD1
22 graves disease 1 32.2 TSHR TPO TG INS
23 stiff-person syndrome 32.2 INS GAD2 GAD1
24 granulomatosis with polyangiitis 32.1 TNFSF13B PTPN22 IL17A CTLA4
25 autoimmune disease of central nervous system 32.1 IL17A IL10 IFNG FOXP3 CTLA4
26 juvenile rheumatoid arthritis 32.0 IL10 IFNG CTLA4
27 lupus erythematosus 32.0 PTPN22 IL10 IFNG CTLA4
28 mixed connective tissue disease 31.9 TNFSF13B IL10 IFNG
29 pernicious anemia 31.9 TPO TG PTPN22 GAD2 AIRE
30 lichen planus 31.8 IL17A IL10 IFNG
31 vogt-koyanagi-harada disease 31.8 PTPN22 IL17A IL10 IFNG
32 myasthenia gravis 31.8 TNFSF13B PTPN22 IL10 IFNG CTLA4 AIRE
33 relapsing polychondritis 31.8 IL17A IL10 IFNG
34 polyendocrinopathy 31.8 FOXP3 AIRE
35 myxedema 31.7 TSHR TPO TG CTLA4
36 collagen disease 31.7 TNFSF13B IL17A IL10
37 chronic inflammatory demyelinating polyradiculoneuropathy 31.7 IL17A IL10 IFNG
38 cryoglobulinemia 31.6 TNFSF13B IL10 IFNG
39 diabetes mellitus, ketosis-prone 31.5 PTPRN INS GAD2 GAD1 CTLA4
40 reactive arthritis 31.5 IL17A IL10 IFNG
41 cutaneous lupus erythematosus 31.4 TNFSF13B IL17A IL10 IFNG
42 graves' disease 31.4 TSHR TPO TG PTPN22 IFNG GAD2
43 systemic scleroderma 31.4 TPO TNFSF13B INS IL17A IFNG
44 hyperthyroidism 31.3 TSHR TPO TG INS CTLA4
45 cholangitis 31.3 IL17A IL10 CTLA4
46 autoimmune disease of musculoskeletal system 31.2 TNFSF13B PTPN22 IL17A IL10 IFNG FOXP3
47 psoriasis 31.2 PTPN22 IL17A IL10 IFNG CTLA4
48 psoriatic arthritis 31.2 PTPN22 IL17A IL10 IFNG CTLA4
49 maturity-onset diabetes of the young 31.2 PTPRN INS GAD2 GAD1
50 alopecia 31.1 IFNG CTLA4 AIRE
51 autoimmune polyendocrine syndrome 31.0 TPO TG INS IL17A IL10 GAD2
52 primary biliary cirrhosis 30.9 IL17A IL10 IFNG FOXP3 CTLA4
53 interstitial lung disease 30.9 IL17A IL10 IFNG FOXP3
54 uveitis 30.8 IL17A IL10 IFNG CTLA4
55 diabetes mellitus, permanent neonatal 30.8 PTPRN INS FOXP3
56 thyroid carcinoma 30.8 TSHR TPO TG
57 thyroid gland disease 30.7 TSHR TPO TG INS
58 myocarditis 30.7 IL17A IL10 IFNG CTLA4
59 peripheral nervous system disease 30.7 INS IL17A IL10 IFNG CTLA4
60 immune deficiency disease 30.6 TNFSF13B RAG1 IL10 IFNG FOXP3
61 common variable immunodeficiency 30.6 TNFSF13B RAG1 IL10 IFNG FOXP3 CTLA4
62 spondylitis 30.6 IL17A IL10 IFNG
63 goiter 30.5 TSHR TPO TG INS
64 candidiasis 30.5 IL17A IL10 IFNG AIRE
65 allergic hypersensitivity disease 30.5 IL17A IL10 IFNG FOXP3 CTLA4
66 t cell deficiency 30.5 RAG1 IL17A CTLA4
67 bronchiolitis obliterans 30.4 IL17A IL10 IFNG FOXP3 CTLA4
68 omenn syndrome 30.4 RAG1 IL10 IFNG FOXP3 AIRE
69 exophthalmos 30.4 TSHR TPO TG
70 subacute thyroiditis 30.3 TSHR TPO TG
71 multiple sclerosis 30.3 TNFSF13B PTPN22 IL17A IL10 IFNG FOXP3
72 transverse myelitis 30.3 IL17A IL10
73 hashimoto thyroiditis 30.3 TSHR TPO TG PTPN22 IL17A IL10
74 temporal arteritis 30.3 PTPN22 IL17A IFNG CTLA4
75 rheumatoid arthritis 30.3 TNFSF13B PTPN22 IL17A IL10 IFNG FOXP3
76 autoimmune disease of gastrointestinal tract 30.3 TPO PTPN22 INS IL17A IL10 IFNG
77 crohn's disease 30.3 PTPN22 IL17A IL10 IFNG
78 keratoconjunctivitis 30.3 IL17A IFNG AIRE
79 endemic goiter 30.3 TSHR TPO TG
80 cutaneous candidiasis 30.2 IL17A AIRE
81 congenital hypothyroidism 30.2 TSHR TPO TG
82 nodular goiter 30.2 TSHR TPO TG CTLA4
83 chronic graft versus host disease 30.2 TNFSF13B IL10 IFNG
84 chronic mucocutaneous candidiasis 30.1 PTPN22 IL17A IL10 IFNG FOXP3 AIRE
85 polyradiculoneuropathy 30.1 IL17A IL10 IFNG
86 severe combined immunodeficiency 30.1 RAG1 IL17A IL10 IFNG
87 hypothyroidism 30.1 TSHR TPO TG PTPN22 INS CTLA4
88 nontoxic goiter 30.1 TSHR TPO TG
89 hepatitis a 30.1 INS IL10 IFNG CTLA4
90 mechanical strabismus 30.1 TPO TG
91 plummer's disease 30.1 TSHR TPO TG
92 bronchiolitis 30.1 IL17A IL10 IFNG
93 turner syndrome 30.1 TPO TG INS
94 viral hepatitis 30.0 INS IL10 IFNG
95 chagas disease 30.0 IL17A IL10 IFNG CTLA4
96 thyroid crisis 30.0 TSHR TPO TG
97 multinodular goiter 30.0 TSHR TPO TG IL10
98 neuromuscular disease 29.9 TNFSF13B PTPN22 IL17A IL10 FOXP3 CTLA4
99 chlamydia 29.9 IL17A IL10 IFNG
100 arthritis 29.9 TNFSF13B PTPN22 IL17A IL10 IFNG FOXP3
101 behcet syndrome 29.9 TNFSF13B PTPN22 IL17A IL10 IFNG FOXP3
102 contact dermatitis 29.9 IL17A IL10 IFNG
103 papillary carcinoma 29.9 TSHR TPO TG
104 hemophagocytic lymphohistiocytosis 29.9 IL10 IFNG CTLA4
105 transient congenital hypothyroidism 29.9 TSHR TPO
106 meningitis 29.9 IL17A IL10 IFNG
107 follicular adenoma 29.8 TSHR TPO TG
108 lung disease 29.8 INS IL17A IL10 IFNG
109 chorioretinitis 29.8 IL17A IL10 IFNG
110 dacryoadenitis 29.8 IL17A IL10 FOXP3
111 alopecia areata 29.8 TPO PTPN22 IL17A IL10 IFNG FOXP3
112 combined t cell and b cell immunodeficiency 29.8 RAG1 IL10 FOXP3 CTLA4
113 proteasome-associated autoinflammatory syndrome 1 29.8 INS IL17A IL10 IFNG
114 demyelinating disease 29.8 IL17A IL10 IFNG FOXP3 CTLA4
115 acute thyroiditis 29.8 TPO TG
116 periodontitis 29.8 IL17A IL10 IFNG
117 neurosyphilis 29.7 IL17A IL10
118 endocarditis 29.7 IL17A IL10 IFNG
119 differentiated thyroid carcinoma 29.7 TSHR TPO TG
120 connective tissue disease 29.7 TNFSF13B INS IL17A IL10 IFNG FOXP3
121 spondyloarthropathy 29.7 IL17A IL10 IFNG
122 brucellosis 29.7 IL17A IL10 IFNG
123 hypothyroidism, congenital, nongoitrous, 2 29.6 TSHR TPO TG
124 allergic contact dermatitis 29.6 IL17A IL10 IFNG
125 kawasaki disease 29.6 IL17A IL10 FOXP3
126 secondary progressive multiple sclerosis 29.6 IL17A IL10 IFNG
127 neonatal thyrotoxicosis 29.6 TSHR TG
128 pulmonary tuberculosis 29.6 IL17A IL10 IFNG
129 otitis media 29.6 IL17A IL10 IFNG
130 thymoma 29.6 TG PTPN22 IL17A FOXP3 CTLA4 AIRE
131 central nervous system vasculitis 29.5 PTPN22 IL17A IFNG CTLA4
132 allergic asthma 29.5 IL17A IL10 IFNG CTLA4
133 struma ovarii 29.5 TSHR TG
134 skin disease 29.5 IL17A IL10 IFNG FOXP3 CTLA4
135 systemic lupus erythematosus 29.5 TPO TNFSF13B PTPN22 INS IL17A IL10
136 prediabetes syndrome 29.5 PTPRN INS GAD1
137 thrombocytopenia 29.5 TNFSF13B IL17A IL10 IFNG FOXP3 CTLA4
138 chronic active epstein-barr virus infection 29.4 IL10 IFNG CTLA4
139 chronic fatigue syndrome 29.4 INS IL17A IL10 IFNG
140 inflammatory bowel disease 29.4 PTPN22 IL17A IL10 IFNG FOXP3 CTLA4
141 dermatitis 29.4 IL17A IL10 IFNG FOXP3 CTLA4
142 athyreosis 29.4 TSHR TG
143 schistosomiasis 29.4 IL17A IL10 IFNG CTLA4
144 pneumonia 29.4 IL17A IL10 IFNG FOXP3
145 echinococcosis 29.3 IL17A IL10 IFNG
146 monocarboxylate transporter 1 deficiency 29.3 INS GAD1
147 metal allergy 29.3 IL17A IL10
148 colitis 29.3 IL17A IL10 IFNG FOXP3 CTLA4
149 filariasis 29.3 IL10 IFNG CTLA4
150 cryptococcosis 29.2 IL17A IL10 IFNG
151 mycoplasma pneumoniae pneumonia 29.2 IL17A IL10 IFNG
152 conjunctivitis 29.2 IL10 IFNG FOXP3
153 appendicitis 29.2 IL17A IL10 IFNG
154 relapsing-remitting multiple sclerosis 29.2 TNFSF13B IL17A IL10 IFNG FOXP3
155 thyroiditis 29.1 TSHR TPO TG PTPN22 INS IL10
156 dermatitis, atopic 29.1 IL17A IL10 IFNG FOXP3 CTLA4
157 visceral leishmaniasis 29.1 IL10 IFNG FOXP3
158 rhinitis 29.1 IL17A IL10 IFNG FOXP3
159 eye disease 29.1 TSHR INS IL17A IL10 IFNG
160 diabetes mellitus, insulin-dependent, 20 29.1 TPO TG INS
161 type 1 diabetes mellitus 2 29.1 PTPN22 INS CTLA4 AIRE
162 bacterial meningitis 29.0 IL17A IL10 IFNG
163 leprosy 3 29.0 IL17A IL10 IFNG FOXP3
164 eales disease 29.0 IL10 IFNG
165 autoimmune disease 29.0 TSHR TPO TNFSF13B TG PTPN22 INS
166 cystic echinococcosis 28.9 IL17A IL10 IFNG
167 splenic disease 28.9 IL17A IL10 IFNG
168 scrub typhus 28.9 IL17A IL10 IFNG
169 immune system disease 28.8 TNFSF13B TG INS IL17A IL10 IFNG
170 autoimmune disease of endocrine system 28.8 TSHR TPO TG PTPRN PTPN22 INS
171 plasmodium vivax malaria 28.8 TNFSF13B IL10 IFNG
172 leishmaniasis 28.7 IL17A IL10 IFNG FOXP3 CTLA4
173 tropical spastic paraparesis 28.7 IL17A IL10 IFNG FOXP3
174 ileus 28.7 INS IL17A IL10 IFNG
175 respiratory allergy 28.7 IL17A IL10 FOXP3
176 trachoma 28.5 IL17A IL10 FOXP3
177 food allergy 28.5 IL17A IL10 IFNG FOXP3 CTLA4
178 myeloma, multiple 28.5 TNFSF13B IL17A IL10 IFNG FOXP3 CTLA4
179 diabetes mellitus, noninsulin-dependent 28.5 TPO PTPRN INS IL10 GAD2 GAD1
180 b cell deficiency 28.5 TNFSF13B RAG1 IL17A IL10 FOXP3 CTLA4
181 celiac disease 1 28.5 TPO TG PTPRN PTPN22 INS IL17A
182 mycosis fungoides 28.3 IFNG FOXP3 CTLA4
183 arteriosclerosis 28.3 INS IL10 IFNG FOXP3
184 diabetes mellitus 28.2 PTPRN PTPN22 INS IL17A IL10 IFNG
185 parasitic helminthiasis infectious disease 28.2 IL17A IL10 IFNG FOXP3
186 cutaneous leishmaniasis 28.2 IL17A IL10 IFNG FOXP3 CTLA4
187 lymphopenia 28.2 RAG1 PTPN22 INS IL10 IFNG GAD2
188 lymph node disease 28.0 IL17A IL10 IFNG FOXP3
189 diabetes mellitus, insulin-dependent 28.0 TSHR TPO TG PTPRN PTPN22 INS
190 asthma 28.0 INS IL17A IL10 IFNG FOXP3 CTLA4
191 malaria 27.6 TNFSF13B INS IL17A IL10 IFNG FOXP3
192 bone inflammation disease 27.4 PTPN22 IL17A IL10 IFNG FOXP3 CTLA4
193 neuromuscular junction disease 27.2 TNFSF13B PTPN22 IL17A IL10 FOXP3 CTLA4
194 ras-associated autoimmune leukoproliferative disorder 12.6
195 autoimmune lymphoproliferative syndrome, type v 12.6
196 autoimmune lymphoproliferative syndrome, type iia 12.5
197 autoimmune disease 1 12.5
198 immunodeficiency, common variable, 8, with autoimmunity 12.5
199 autoimmune polyglandular syndrome type 3 12.5
200 autoimmune lymphoproliferative syndrome, type iii 12.5
201 thrombocytopenic purpura, autoimmune 12.5
202 autoimmune disease, multisystem, infantile-onset, 1 12.5
203 autoimmune disease, multisystem, with facial dysmorphism 12.4
204 t-cell immunodeficiency, recurrent infections, and autoimmunity with or without cardiac malformations 12.4
205 autoimmune interstitial lung, joint, and kidney disease 12.4
206 autoimmune disease 6 12.4
207 autoimmune oophoritis 12.4
208 autoimmune thyroid disease 3 12.4
209 autoimmune disease, multisystem, infantile-onset, 2 12.4
210 drug-induced autoimmune hemolytic anemia 12.4
211 autoimmune encephalitis 12.4
212 vitiligo-associated multiple autoimmune disease susceptibility 6 12.4
213 autoimmune retinopathy 12.4
214 autoimmune progesterone dermatitis 12.4
215 autoimmune myocarditis 12.4
216 immunodeficiency 41 with lymphoproliferation and autoimmunity 12.4
217 pediatric autoimmune neuropsychiatric disorders associated with streptococcus infections 12.4
218 autoimmune atrophic gastritis 12.4
219 autoimmune autonomic ganglionopathy 12.4
220 autoimmune thyroid disease 2 12.3
221 immunodeficiency 63 with lymphoproliferation and autoimmunity 12.3
222 autoimmune inner ear disease 12.3
223 necrotizing autoimmune myopathy 12.3
224 autoimmune neuropathy 12.3
225 autoimmune peripheral neuropathy 12.3
226 autoimmune polyendocrinopathy type 3 12.3
227 autoimmune glomerulonephritis 12.3
228 autoimmune vasculitis 12.3
229 autoimmune optic neuritis 12.3
230 autoimmune gastrointestinal dysmotility 12.3
231 autoimmune cardiomyopathy 12.3
232 autoimmune polyendocrinopathy type 4 12.3
233 autoimmune atherosclerosis 12.3
234 autoimmune disease of peripheral nervous system 12.3
235 dianzani autoimmune lymphoproliferative disease 12.2
236 autoimmune disease 3 12.2
237 autoimmune disease 2 12.2
238 autoimmune disease 4 12.2
239 autoimmune hemolytic anemia, warm type 12.2
240 mixed-type autoimmune hemolytic anemia 12.2
241 autoimmune hemolytic anemia, cold type 12.2
242 autoimmune disease of skin and connective tissue 12.2
243 autoimmune thyroid disease 1 12.2
244 autoimmune thyroid disease 4 12.2
245 autoimmune hypoparathyroidism 12.2
246 myasthenia, limb-girdle, autoimmune 12.1
247 autoimmune disease of exocrine system 12.1
248 autoimmune pancreatitis type 1 12.1
249 seronegative autoimmune hepatitis 12.1
250 autoimmune bullous skin disease 12.1
251 primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome 12.1
252 autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome 12.1
253 autoimmune hepatitis type 1 12.1
254 autoimmune hepatitis type 2 12.1
255 neonatal autoimmune hemolytic anemia 12.1
256 autoimmune pancreatitis type 2 12.1
257 lymphopenic hypergammaglobulinemia, antibody deficiency, autoimmune hemolytic anemia, and glomerulonephritis 12.1
258 diabetes mellitus, congenital autoimmune 12.1
259 obsolete: vitiligo-associated autoimmune disease 12.1
260 caspase 8 deficiency 12.0
261 allergic encephalomyelitis 12.0
262 hirata disease 12.0
263 pulmonary alveolar proteinosis, acquired 12.0
264 obsolete: other ganglionopathy related to autoimmune diseases 12.0
265 secondary neonatal autoimmune disease 12.0
266 spondyloenchondrodysplasia with immune dysregulation 12.0
267 evans' syndrome 11.9
268 sjogren's syndrome, juvenile, secondary to autoimmune disease 11.9
269 inflammatory and autoimmune disease with epilepsy 11.9
270 immunodeficiency syndrome with autoimmunity 11.9
271 mixed autoinflammatory and autoimmune syndrome 11.9
272 autoimmune disease with skin involvement 11.9
273 postinfectious autoimmune disease with chorea 11.9
274 autoimmune encephalopathy with parasomnia and obstructive sleep apnea 11.9
275 autoimmune/inflammatory optic neuropathy 11.9
276 obsolete: inflammatory/autoimmune optic neuropathy 11.9
277 inflammatory/autoimmune disorder involving the lacrimal system 11.9
278 rare inflammatory/autoimmune corneal disorder 11.9
279 rare genetic inflammatory/autoimmune corneal disorder 11.9
280 syndromic autoimmune enteropathy 11.9
281 primary autoimmune enteropathy 11.9
282 autoimmune neurological channelopathy 11.9
283 obsolete: autoimmune neurological channelopathy due to a p/q-type voltage gated calcium channel defect 11.9
284 obsolete: autoimmune neurological channelopathy due to a potassium channel defect 11.9
285 obsolete: autoimmune neurological channelopathy due to an acetylcholine receptor subunits defect 11.9
286 obsolete: male infertility with normal virilization due to acquired testicular defect associated with autoimmunity 11.9
287 obsolete: male infertility with impaired virilization due to an acquired testicular defect associated with autoimmunity 11.9
288 obsolete: autoimmune enteropathy type 3 11.9
289 obsolete: autoimmune enteropathy type 2 11.9
290 lymphocytic hypophysitis 11.9
291 warm antibody hemolytic anemia 11.9
292 guillain-barre syndrome 11.9
293 hyperthyroidism, nonautoimmune 11.9
294 igg4-related disease 11.9
295 celiac disease 6 11.8
296 thrombocytopenia due to platelet alloimmunization 11.7
297 sjogren syndrome 11.7
298 antiphospholipid syndrome 11.7
299 cold agglutinin disease 11.7
300 hypothyroidism, congenital, nongoitrous, 1 11.7
301 vasculitis 11.6
302 neuromyelitis optica 11.6
303 pemphigus 11.6
304 bullous pemphigoid 11.6
305 itch e3 ubiquitin ligase deficiency 11.6
306 lambert-eaton myasthenic syndrome 11.5
307 familial cold autoinflammatory syndrome 3 11.5
308 cholangitis, primary sclerosing 11.5
309 pediatric acute-onset neuropsychiatric syndrome 11.5
310 pulmonary alveolar proteinosis 11.5
311 complement component 2 deficiency 11.5
312 immunodeficiency 31c 11.5
313 scleroderma, familial progressive 11.5
314 pancreatitis 11.5
315 goodpasture syndrome 11.5
316 acquired generalized lipodystrophy 11.5
317 purine nucleoside phosphorylase deficiency 11.5
318 undifferentiated connective tissue disease 11.4
319 epidermolysis bullosa acquisita 11.4
320 premature ovarian failure 1 11.4
321 henoch-schoenlein purpura 11.4
322 dermatomyositis 11.4
323 thrombotic thrombocytopenic purpura, acquired 11.4
324 polymyositis 11.4
325 hypoparathyroidism 11.4
326 pemphigus vulgaris, familial 11.4
327 paroxysmal cold hemoglobinuria 11.4
328 atrophic gastritis 11.4
329 gastritis 11.4
330 severe immune-mediated enteropathy 11.4
331 exanthem 11.4
332 reye syndrome 11.4
333 primary hypophysitis 11.4
334 mikulicz disease 11.4
335 dermatitis herpetiformis 11.3
336 raynaud phenomenon 11.3
337 aplastic anemia 11.3
338 cicatricial pemphigoid 11.3
339 pemphigoid gestationis 11.3
340 alopecia universalis congenita 11.3
341 lymphomatous thyroiditis 11.3
342 microscopic polyangiitis 11.3
343 churg-strauss syndrome 11.3
344 wiskott-aldrich syndrome 11.3
345 rheumatic disease 11.3
346 cogan syndrome 11.3
347 myositis 11.3
348 immunoglobulin a deficiency 1 11.3
349 hypogonadotropic hypogonadism 11.3
350 felty syndrome 11.3
351 digeorge syndrome 11.3
352 alopecia totalis 11.3
353 acquired angioedema 11.3
354 dilated cardiomyopathy 11.3
355 melanoma-associated retinopathy 11.3
356 episodic ataxia 11.3
357 antisynthetase syndrome 11.3
358 nodular regenerative hyperplasia 11.3
359 aicardi-goutieres syndrome 11.3
360 acquired von willebrand syndrome 11.3
361 eosinophilia-myalgia syndrome 11.3
362 reynolds syndrome 11.3
363 drug-induced lupus erythematosus 11.3
364 aicardi-goutieres syndrome 1 11.3
365 vitreoretinopathy, neovascular inflammatory 11.3
366 complement component 3 deficiency, autosomal recessive 11.3
367 erythromelalgia 11.3
368 transient neonatal myasthenia gravis 11.3
369 juvenile myasthenia gravis 11.3
370 adult-onset myasthenia gravis 11.3
371 satoyoshi syndrome 11.3
372 lipodystrophy, partial, acquired 11.3
373 autoinflammation with arthritis and dyskeratosis 11.3
374 immunodeficiency 52 11.3
375 immunodeficiency 64 11.3
376 optic neuritis 11.2
377 rickets 11.2
378 pure red-cell aplasia 11.2
379 pemphigus foliaceus 11.2
380 pulmonary fibrosis 11.2
381 membranous nephropathy 11.2
382 paraneoplastic pemphigus 11.2
383 ocular cicatricial pemphigoid 11.2
384 anca-associated vasculitis 11.2
385 heart block, congenital 11.2
386 narcolepsy 11.2
387 autonomic dysfunction 11.2
388 multifocal motor neuropathy 11.2
389 immunodeficiency 60 11.2
390 rheumatic heart disease 11.2
391 membranoproliferative glomerulonephritis 11.2
392 discoid lupus erythematosus 11.2
393 pemphigus gestationis 11.2
394 dysautonomia 11.2
395 acquired hemophilia 11.2
396 adult-onset still's disease 11.2
397 lichen sclerosus et atrophicus 11.2
398 acute disseminated encephalomyelitis 11.2
399 retinal vasculitis 11.2
400 childhood type dermatomyositis 11.2
401 allergic angiitis 11.2
402 crest syndrome 11.2
403 peritonitis 11.2
404 familial mediterranean fever 11.2
405 sudden sensorineural hearing loss 11.2
406 chronic granulomatous disease 11.2
407 distal renal tubular acidosis 11.2
408 systemic onset juvenile idiopathic arthritis 11.2
409 miller fisher syndrome 11.2
410 biliary atresia 11.2
411 angioimmunoblastic t-cell lymphoma 11.2
412 takayasu arteritis 11.1
413 eosinophilic fasciitis 11.1
414 pars planitis 11.1
415 progressive multifocal leukoencephalopathy 11.1
416 c1q deficiency 11.1
417 complex regional pain syndrome 11.1
418 bullous skin disease 11.1
419 buerger disease 11.1
420 gastroparesis 11.1
421 kikuchi disease 11.1
422 systemic lupus erythematosus 1 11.1
423 acquired hemophilia a 11.1
424 opsoclonus-myoclonus syndrome 11.1
425 lymphocytic colitis 11.1
426 acute zonal occult outer retinopathy 11.1
427 selective igm deficiency disease 11.1
428 severe congenital neutropenia 11.1
429 congenital myasthenic syndrome 11.1
430 frontal fibrosing alopecia 11.1
431 cartilage-hair hypoplasia 11.1
432 systemic lupus erythematosus 11 11.1
433 complement component 4a deficiency 11.1
434 transient neonatal diabetes mellitus 11.1
435 endocrine exophthalmos 11.1
436 acquired pure red cell aplasia 11.1
437 familial glucocorticoid deficiency 11.1
438 linear scleroderma 11.1
439 spondyloenchondrodysplasia 11.1
440 susac syndrome 11.1
441 systemic lupus erythematosus 2 11.1
442 rippling muscle disease 2 11.1
443 systemic lupus erythematosus 10 11.1
444 t-cell lymphoma, subcutaneous panniculitis-like 11.1
445 limited scleroderma 11.1
446 complement component 3 deficiency 11.1
447 ichthyosis, acquired 11.1
448 wells syndrome 11.1
449 aplasia of lacrimal and salivary glands 11.1
450 immunodeficiency with hyper-igm, type 1 11.1
451 aortic aneurysm, familial thoracic 1 11.1
452 myasthenic syndrome, congenital, 12 11.1
453 multiple sclerosis 5 11.1
454 immunodeficiency 14 11.1
455 vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome 11.1
456 inflammatory diarrhea 11.1
457 gamma heavy chain disease 11.1
458 spinal cord disease 11.1
459 chronic relapsing inflammatory optic neuropathy 11.1
460 bickerstaff brainstem encephalitis 11.1
461 alopecia areata 1 11.1
462 hemifacial atrophy, progressive 11.1
463 velocardiofacial syndrome 11.1
464 tn polyagglutination syndrome 11.1
465 thrombocytopenia 1 11.1
466 microvascular complications of diabetes 1 11.1
467 birdshot chorioretinopathy 11.1
468 acute hemorrhagic leukoencephalitis 11.1
469 cinca syndrome 11.1
470 systemic lupus erythematosus 6 11.1
471 systemic lupus erythematosus 9 11.1
472 immunodeficiency 10 11.1
473 complement component 4b deficiency 11.1
474 systemic lupus erythematosus 16 11.1
475 palindromic rheumatism 11.1
476 selective igg deficiency disease 11.1
477 capillary leak syndrome 11.1
478 facial hemiatrophy 11.1
479 prothrombin deficiency 11.1
480 gastric antral vascular ectasia 11.1
481 collagenous gastritis 11.1
482 fibrillary glomerulonephritis 11.1
483 glucagonoma 11.1
484 idiopathic hypertrophic pachymeningitis 11.1
485 perniosis 11.1
486 hemolytic anemia 11.1
487 insulin-resistance type b 11.0
488 deficiency anemia 11.0
489 candidiasis, familial, 6 10.9
490 allergic cutaneous vasculitis 10.9
491 antiphospholipid syndrome, familial 10.9
492 guillain-barre syndrome, familial 10.9
493 sneddon syndrome 10.9
494 epilepsy with bilateral occipital calcifications 10.9
495 complement factor i deficiency 10.9
496 lymphoproliferative syndrome 1 10.9
497 masp2 deficiency 10.9
498 immunodeficiency, common variable, 10 10.9
499 immunodeficiency 17 10.9
500 proteasome-associated autoinflammatory syndrome 2 10.9
501 familial hypocalciuric hypercalcemia 10.9
502 idiopathic cd4-positive t-lymphocytopenia 10.9
503 parsonage turner syndrome 10.9
504 pgm3-congenital disorder of glycosylation 10.9
505 hepatitis 10.9
506 liver disease 10.9
507 purpura 10.9
508 glomerulonephritis 10.8
509 encephalitis 10.8
510 fundus albipunctatus 10.8
511 yellow nail syndrome 10.8
512 iga nephropathy 1 10.8
513 bronchiectasis with or without elevated sweat chloride 1 10.8
514 hypothyroidism, congenital, nongoitrous, 5 10.8
515 epiphyseal dysplasia, multiple, with early-onset diabetes mellitus 10.8
516 ermine phenotype 10.8
517 thiamine-responsive megaloblastic anemia syndrome 10.8
518 pseudo-torch syndrome 1 10.8
519 myasthenic syndrome, congenital, 6, presynaptic 10.8
520 myasthenic syndrome, congenital, 10 10.8
521 chronic recurrent multifocal osteomyelitis 10.8
522 megaloblastic anemia 1 10.8
523 surfactant metabolism dysfunction, pulmonary, 1 10.8
524 diarrhea 3, secretory sodium, congenital, with or without other congenital anomalies 10.8
525 myasthenic syndrome, congenital, 5 10.8
526 reflex sympathetic dystrophy 10.8
527 myasthenic syndrome, congenital, 4a, slow-channel 10.8
528 myasthenic syndrome, congenital, 1b, fast-channel 10.8
529 myasthenic syndrome, congenital, 4c, associated with acetylcholine receptor deficiency 10.8
530 immunoglobulin a deficiency 2 10.8
531 thiopurines, poor metabolism of, 1 10.8
532 multiple sclerosis 3 10.8
533 bronchiectasis with or without elevated sweat chloride 2 10.8
534 bronchiectasis with or without elevated sweat chloride 3 10.8
535 infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations 10.8
536 ficolin 3 deficiency 10.8
537 myasthenic syndrome, congenital, 16 10.8
538 bleeding disorder, platelet-type, 11 10.8
539 blood group, john milton hagen system 10.8
540 myasthenic syndrome, congenital, 13 10.8
541 myasthenic syndrome, congenital, 8 10.8
542 facial dysmorphism, immunodeficiency, livedo, and short stature 10.8
543 melioidosis 10.8
544 immunodeficiency 36 10.8
545 myasthenic syndrome, congenital, 7, presynaptic 10.8
546 polyendocrine-polyneuropathy syndrome 10.8
547 myasthenic syndrome, congenital, 22 10.8
548 myasthenic syndrome, congenital, 15 10.8
549 myasthenic syndrome, congenital, 14 10.8
550 myasthenic syndrome, congenital, 17 10.8
551 myasthenic syndrome, congenital, 2a, slow-channel 10.8
552 myasthenic syndrome, congenital, 2c, associated with acetylcholine receptor deficiency 10.8
553 myasthenic syndrome, congenital, 3a, slow-channel 10.8
554 myasthenic syndrome, congenital, 3b, fast-channel 10.8
555 myasthenic syndrome, congenital, 3c, associated with acetylcholine receptor deficiency 10.8
556 myasthenic syndrome, congenital, 4b, fast-channel 10.8
557 myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency 10.8
558 myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency 10.8
559 myasthenic syndrome, congenital, 18 10.8
560 immunodeficiency, common variable, 12 10.8
561 myasthenic syndrome, congenital, 19 10.8
562 myasthenic syndrome, congenital, 20, presynaptic 10.8
563 myasthenic syndrome, congenital, 21, presynaptic 10.8
564 yao syndrome 10.8
565 immunodeficiency 53 10.8
566 myasthenic syndrome, congenital, 23, presynaptic 10.8
567 myasthenic syndrome, congenital, 24, presynaptic 10.8
568 myasthenic syndrome, congenital, 25, presynaptic 10.8
569 juvenile ankylosing spondylitis 10.8
570 immunoglobulin beta deficiency 10.8
571 sting-associated vasculopathy with onset in infancy 10.8
572 autonomic nervous system disease 10.8
573 hypopigmentation of eyelid 10.8
574 thyrotoxic exophthalmos 10.8
575 jaccoud's syndrome 10.8
576 frozen shoulder 10.8
577 cryptosporidiosis 10.8
578 causalgia 10.8
579 atrophic rhinitis 10.8
580 diffuse pulmonary fibrosis 10.8
581 localized pulmonary fibrosis 10.8
582 selective ige deficiency disease 10.8
583 subcorneal pustular dermatosis 10.8
584 alezzandrini syndrome 10.8
585 brunsting-perry syndrome 10.8
586 enthesitis-related juvenile idiopathic arthritis 10.8
587 granulomatous lobular mastitis 10.8
588 immunotactoid glomerulopathy 10.8
589 immunotactoid or fibrillary glomerulopathy 10.8
590 localized lipodystrophy 10.8
591 plummer vinson syndrome 10.8
592 postorgasmic illness syndrome 10.8
593 pseudopelade of brocq 10.8
594 psoriatic juvenile idiopathic arthritis 10.8
595 punctate inner choroidopathy 10.8
596 myoclonic encephalopathy of infants 10.8
597 hughes-stovin syndrome 10.8
598 vulvovaginal gingival syndrome 10.8
599 sclerosing cholangitis 10.8
600 liver cirrhosis 10.7
601 neuritis 10.7
602 neutropenia 10.7
603 paroxysmal nocturnal hemoglobinuria 10.7
604 lymphoproliferative syndrome 10.7
605 cytokine deficiency 10.6
606 splenomegaly 10.6
607 ulcerative colitis 10.6
608 hepatitis c 10.6
609 myopathy 10.6
610 urticaria 10.6
611 pancreatic cancer 10.6
612 pertussis 10.6
613 lymphocytic leukemia 10.6
614 pustulosis of palm and sole 10.6
615 graft-versus-host disease 10.6
616 encephalopathy 10.6
617 sarcoidosis 1 10.5
618 inflammatory spondylopathy 10.5
619 leukemia, chronic lymphocytic 10.5
620 spondyloarthropathy 1 10.5
621 lymphoma 10.5
622 thymoma, familial 10.5
623 hepatitis c virus 10.5
624 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.5
625 orchitis 10.5
626 hypoglycemia 10.5
627 obstructive jaundice 10.5
628 sensorineural hearing loss 10.5
629 polyneuropathy 10.5
630 sialadenitis 10.5
631 neuropathy 10.5
632 ataxia and polyneuropathy, adult-onset 10.5
633 epidermolysis bullosa 10.4
634 cholestasis 10.4
635 infertility 10.4
636 inner ear disease 10.4
637 insulinoma 10.4
638 atherosclerosis susceptibility 10.4
639 hyperglycemia 10.4
640 acute liver failure 10.4
641 familial thyroid dyshormonogenesis 10.4 TPO TG
642 lymphoma, hodgkin, classic 10.4
643 atrial standstill 1 10.4
644 red cell aplasia 10.4
645 nonencapsulated sclerosing carcinoma 10.4 TPO TG
646 prostatitis 10.4
647 bacterial infectious disease 10.4
648 b-cell lymphoma 10.4
649 goiter, multinodular 1, with or without sertoli-leydig cell tumors 10.4 TPO TG
650 dermatitis herpetiformis, familial 10.4
651 vascular disease 10.4
652 pancytopenia 10.4
653 myelodysplastic syndrome 10.4
654 rare acquired hemolytic anemia 10.4
655 yemenite deaf-blind hypopigmentation syndrome 10.4
656 diarrhea 10.4
657 iridocyclitis 10.4
658 demyelinating polyneuropathy 10.4
659 autosomal recessive disease 10.4
660 retroperitoneal fibrosis 10.4
661 immunoglobulin alpha deficiency 10.3
662 leukemia 10.3
663 idiopathic interstitial pneumonia 10.3
664 helicobacter pylori infection 10.3
665 epilepsy 10.3
666 rheumatic fever 10.3
667 iron metabolism disease 10.3
668 acute pancreatitis 10.3
669 polyarteritis nodosa 10.3
670 aceruloplasminemia 10.3
671 lymphoma, non-hodgkin, familial 10.3
672 agammaglobulinemia 10.3
673 thrombotic thrombocytopenic purpura 10.3
674 wissler's syndrome 10.3 PTPRN AIRE
675 chronic orbital inflammation 10.3 TSHR CTLA4
676 hypereosinophilic syndrome 10.3
677 fibrosis of extraocular muscles, congenital, 1 10.3
678 chorea, childhood-onset, with psychomotor retardation 10.3
679 interstitial nephritis 10.3
680 choreatic disease 10.3
681 fibromyalgia 10.3
682 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 10.3
683 hepatitis b 10.3
684 47,xyy 10.3
685 neuroretinitis 10.3
686 angioedema 10.3
687 hypogonadism 10.3
688 myelitis 10.3
689 hypogonadotropism 10.3
690 herpes simplex 10.3
691 obsessive-compulsive disorder 10.3
692 retinitis 10.3
693 enthesopathy 10.3
694 tetanus 10.3
695 hypopituitarism 10.3
696 diabetes insipidus 10.3
697 nephrotic syndrome 10.3
698 melanoma 10.3
699 anal spasm 10.3 PTPRN GAD2 AIRE
700 kidney disease 10.3
701 myelofibrosis 10.3
702 status epilepticus 10.3
703 portal hypertension 10.3
704 movement disease 10.3
705 adenoma 10.3
706 ige responsiveness, atopic 10.2
707 tic disorder 10.2
708 homologous wasting disease 10.2
709 paraneoplastic syndromes 10.2
710 pre-eclampsia 10.2
711 endometriosis 10.2
712 posterior uveitis 10.2
713 myoclonus 10.2
714 thyroid gland anaplastic carcinoma 10.2 TPO TG
715 erythema multiforme 10.2
716 heart disease 10.2
717 lymphocytic choriomeningitis 10.2
718 angelucci's syndrome 10.2 IL17A IFNG
719 autism 10.2
720 aging 10.2
721 hyperprolactinemia 10.2
722 arthropathy 10.2
723 retinal degeneration 10.2
724 measles 10.2
725 hepatocellular carcinoma 10.2
726 ovarian disease 10.2
727 seizure disorder 10.2
728 postsurgical hypothyroidism 10.2 TSHR TG
729 cholangiocarcinoma 10.2
730 intrahepatic cholangiocarcinoma 10.2
731 tremor 10.2
732 palladium allergic contact dermatitis 10.2 IL17A IL10
733 aland island eye disease 10.2
734 crohn's colitis 10.2
735 adenocarcinoma 10.2
736 chickenpox 10.2
737 fatty liver disease 10.2
738 cryoglobulinemia, familial mixed 10.2
739 branchiootic syndrome 1 10.2
740 diffuse large b-cell lymphoma 10.2
741 cystitis 10.2
742 respiratory failure 10.2
743 visual epilepsy 10.2
744 keratitis, hereditary 10.2
745 polycystic ovary syndrome 10.2
746 cholera 10.2
747 pancreatic ductal adenocarcinoma 10.2
748 granulocytopenia 10.2
749 pfeiffer syndrome 10.2
750 pulmonary hypertension 10.2
751 acquired immunodeficiency syndrome 10.2
752 down syndrome 10.2
753 autonomic neuropathy 10.2
754 hemoglobinuria 10.2
755 primary adrenal insufficiency 10.2
756 gestational diabetes 10.2
757 keratoconjunctivitis sicca 10.2
758 crescentic glomerulonephritis 10.2
759 lateral sclerosis 10.2
760 pancreatic adenocarcinoma 10.2
761 rubella 10.2
762 amyotrophic lateral sclerosis 1 10.2
763 gonadal dysgenesis 10.2
764 pericarditis 10.2
765 localized scleroderma 10.2
766 acute graft versus host disease 10.2
767 linear iga disease 10.2
768 neuromyelitis optica spectrum disorder 10.2
769 hemopericardium 10.2
770 pericardial effusion 10.2
771 teratoma 10.2
772 triiodothyronine receptor auxiliary protein 10.2
773 vitamin b12 deficiency 10.2
774 amenorrhea 10.2
775 iga glomerulonephritis 10.2
776 acute kidney failure 10.2
777 proliferative glomerulonephritis 10.2
778 sleep disorder 10.2
779 cytomegalovirus infection 10.2
780 neurofibromatosis, type ii 10.2
781 inclusion body myositis 10.2
782 pulmonary fibrosis, idiopathic 10.2
783 schizophrenia 10.2
784 marginal zone b-cell lymphoma 10.2
785 diphtheria 10.2
786 immune-complex glomerulonephritis 10.2
787 premature ovarian failure 7 10.2
788 iron deficiency anemia 10.2
789 synovitis 10.2
790 syphilis 10.2
791 nervous system disease 10.2
792 stomatitis 10.2
793 dysphagia 10.2
794 cancer-associated retinopathy 10.2
795 iodine hypothyroidism 10.1 TSHR TPO TG
796 cerebral sinovenous thrombosis 10.1 IL17A IL10
797 osteoporosis 10.1
798 allergic rhinitis 10.1
799 meningoencephalitis 10.1
800 interstitial cystitis 10.1
801 herpes zoster 10.1
802 depression 10.1
803 spinal cord injury 10.1
804 toxic diffuse goiter 10.1 TSHR TPO TG
805 thrombophilia due to thrombin defect 10.1
806 human immunodeficiency virus type 1 10.1
807 acute myocarditis 10.1
808 rapidly involuting congenital hemangioma 10.1
809 subacute lymphocytic thyroiditis 10.1 TSHR TPO TG
810 bone mineral density quantitative trait locus 8 10.1
811 bone mineral density quantitative trait locus 15 10.1
812 non-alcoholic fatty liver disease 10.1
813 dementia 10.1
814 gout 10.1
815 ocular motor apraxia 10.1
816 thrombosis 10.1
817 thalassemia 10.1
818 male infertility 10.1
819 vaccinia 10.1
820 cerebellar degeneration 10.1
821 giant cell myocarditis 10.1
822 breast cancer 10.1
823 pancreatic agenesis 1 10.1
824 optic nerve disease 10.1
825 pancreas disease 10.1
826 central nervous system disease 10.1
827 amyloidosis 10.1
828 hemophilia 10.1
829 pure autonomic failure 10.1
830 chronic pain 10.1
831 bone sarcoma 10.1 IL10 CTLA4
832 hypercholesterolemia, familial, 1 10.1
833 dowling-degos disease 1 10.1
834 autism spectrum disorder 10.1
835 non-alcoholic steatohepatitis 10.1
836 glioma 10.1
837 papillary thyroid microcarcinoma 10.1 TSHR TG
838 varicose veins 10.1
839 renal tubular acidosis 10.1
840 constipation 10.1
841 persian gulf syndrome 10.1
842 pituitary gland disease 10.1
843 dystonia 10.1
844 glial tumor 10.1
845 chemical colitis 10.1 IL17A IL10
846 benign struma ovarii 10.1 TSHR TG PTPRN
847 lymphoma, mucosa-associated lymphoid type 10.1
848 pulmonary hypertension, primary, 1 10.1
849 intraocular pressure quantitative trait locus 10.1
850 bilirubin metabolic disorder 10.1
851 lipid metabolism disorder 10.1
852 pyoderma 10.1
853 thyroid cancer, nonmedullary, 1 10.1
854 lung cancer 10.1
855 pulmonary disease, chronic obstructive 10.1
856 mumps 10.1
857 glucose intolerance 10.1
858 hyperinsulinism 10.1
859 thyroid gland papillary carcinoma 10.1
860 hepatitis e 10.1
861 myeloid leukemia 10.1
862 macroglobulinemia 10.1
863 hansen's disease 10.1
864 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.1
865 retinitis pigmentosa 10.1
866 atrioventricular block 10.1
867 eclampsia 10.1
868 mood disorder 10.1
869 congestive heart failure 10.1
870 t-cell leukemia 10.1
871 placenta disease 10.1
872 end stage renal failure 10.1
873 igg4-related sclerosing cholangitis 10.1
874 teratoma, ovarian 10.1
875 asplenia, isolated congenital 10.1
876 hydrops, lactic acidosis, and sideroblastic anemia 10.1
877 auditory system disease 10.1
878 ovarian germ cell teratoma 10.1
879 cataract 10.1
880 influenza 10.1
881 chromosomal triplication 10.1
882 oral lichen planus 10.1
883 mycetoma 10.1 IL17A IL10
884 meniere disease 10.1
885 kala-azar 1 10.1
886 silicosis 10.1
887 lyme disease 10.1
888 gastrointestinal system disease 10.1
889 pyoderma gangrenosum 10.1
890 aphasia 10.0
891 scleritis 10.0
892 oral candidiasis 10.0
893 rapidly progressive glomerulonephritis 10.0
894 hypersplenism 10.0
895 chronic kidney disease 10.0
896 48,xyyy 10.0
897 growth hormone deficiency 10.0
898 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 10.0
899 histiocytosis 10.0
900 retinal disease 10.0
901 alzheimer disease 10.0
902 hypertriglyceridemia, familial 10.0
903 leukemia, acute myeloid 10.0
904 mycobacterium tuberculosis 1 10.0
905 gastric cancer 10.0
906 bone resorption disease 10.0
907 panuveitis 10.0
908 telangiectasis 10.0
909 toxic shock syndrome 10.0
910 hepatitis d 10.0
911 polyclonal hypergammaglobulinemia 10.0
912 cerebrovascular disease 10.0
913 pulmonary embolism 10.0
914 heparin-induced thrombocytopenia 10.0
915 herpes simplex encephalitis 10.0
916 hypoadrenalism 10.0
917 headache 10.0
918 traumatic brain injury 10.0
919 glomerular disease 10.0
920 small cell cancer of the lung 10.0
921 major affective disorder 8 10.0
922 major affective disorder 9 10.0
923 disseminated intravascular coagulation 10.0
924 hemolytic-uremic syndrome 10.0
925 hereditary spherocytosis 10.0
926 acute cystitis 10.0
927 labyrinthitis 10.0
928 calcinosis 10.0
929 drug-induced hepatitis 10.0
930 gastroenteritis 10.0
931 thrombophilia 10.0
932 nonspecific interstitial pneumonia 10.0
933 hairy cell leukemia 10.0
934 bipolar disorder 10.0
935 complement deficiency 10.0
936 viral encephalitis 10.0
937 osteoarthritis 10.0
938 macrophagic myofasciitis 10.0
939 pancreatic cystadenoma 10.0 PTPRN INS GAD2
940 factor viii deficiency 10.0
941 renal cell carcinoma, nonpapillary 10.0
942 hemophilia a 10.0
943 coronary heart disease 1 10.0
944 tonsillitis 10.0
945 hemosiderosis 10.0
946 hyperparathyroidism 10.0
947 skin carcinoma 10.0
948 aortic aneurysm 10.0
949 pneumonic plague 10.0 IL17A IL10
950 retinal detachment 10.0
951 cystic fibrosis 10.0
952 enterocolitis 10.0
953 auditory neuropathy and optic atrophy 10.0
954 small cell carcinoma 10.0
955 chronic myelomonocytic leukemia 10.0
956 castleman disease 10.0
957 hyperinsulinemic hypoglycemia 10.0
958 panniculitis 10.0
959 neuroendocrine tumor 10.0
960 macular retinal edema 10.0
961 irritable bowel syndrome 10.0
962 muscular dystrophy 10.0
963 sickle cell disease 10.0
964 fasting hypoglycemia 10.0
965 rosai-dorfman disease 10.0
966 syncope 10.0
967 toxic oil syndrome 10.0
968 thrombotic microangiopathy 10.0
969 autoinflammatory syndrome 10.0
970 nickel allergic contact dermatitis 10.0 IL10 IFNG
971 aortic aneurysm, familial abdominal, 1 10.0
972 kaposi sarcoma 10.0
973 migraine with or without aura 1 10.0
974 hemochromatosis, type 1 10.0
975 microvascular complications of diabetes 5 10.0
976 splenic marginal zone lymphoma 10.0
977 ptosis 10.0
978 aseptic meningitis 10.0
979 porphyria 10.0
980 lymphadenitis 10.0
981 cholecystitis 10.0
982 achalasia 10.0
983 bronchiectasis 10.0
984 fasciitis 10.0
985 macrophage activation syndrome 10.0
986 paraneoplastic cerebellar degeneration 10.0
987 brain injury 10.0
988 spasticity 10.0
989 posttransplant acute limbic encephalitis 10.0
990 subacute cutaneous lupus erythematosus 10.0
991 rare hereditary hemochromatosis 10.0
992 refractory anemia 10.0
993 inflammatory bowel disease 18 10.0 RAG1 IL17A IL10 CTLA4
994 bladder cancer 10.0
995 colorectal cancer 10.0
996 creutzfeldt-jakob disease 10.0
997 parkinson disease, late-onset 10.0
998 severe cutaneous adverse reaction 10.0
999 primary progressive multiple sclerosis 10.0
1000 follicular lymphoma 10.0
1001 interleukin-7 receptor alpha deficiency 10.0
1002 xerophthalmia 10.0
1003 anhidrosis 10.0
1004 esophageal varix 10.0
1005 pneumocystosis 10.0
1006 pharyngitis 10.0
1007 keratopathy 10.0
1008 peptic ulcer disease 10.0
1009 viral infectious disease 10.0
1010 aneurysm 10.0
1011 erythema multiforme major 10.0
1012 pik3ca-related overgrowth syndrome 10.0
1013 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 10.0
1014 spotted fever 10.0 IL10 IFNG CTLA4
1015 spotted fever rickettsiosis 10.0 IL10 IFNG CTLA4
1016 orofacial granulomatosis 10.0 IL10 IFNG
1017 orange allergy 10.0 TPO FOXP3
1018 bleeding disorder, platelet-type, 14 9.9 INS IFNG
1019 cardiac conduction defect 9.9
1020 hand skill, relative 9.9
1021 porphyria cutanea tarda 9.9
1022 rheumatic fever-related antigen 9.9
1023 insulin-like growth factor i 9.9
1024 stroke, ischemic 9.9
1025 macular degeneration, age-related, 1 9.9
1026 anxiety 9.9
1027 leukemia, chronic myeloid 9.9
1028 sleep apnea 9.9
1029 nodal marginal zone lymphoma 9.9
1030 amnestic disorder 9.9
1031 sympathetic ophthalmia 9.9
1032 hepatic coma 9.9
1033 46 xx gonadal dysgenesis 9.9
1034 alcohol use disorder 9.9
1035 mental depression 9.9
1036 granuloma annulare 9.9
1037 alcoholic pancreatitis 9.9
1038 intestinal disease 9.9
1039 monoclonal gammopathy of uncertain significance 9.9
1040 subacute delirium 9.9
1041 diabetic neuropathy 9.9
1042 acanthosis nigricans 9.9
1043 ovarian cancer 9.9
1044 pituitary hormone deficiency, combined, 2 9.9
1045 body mass index quantitative trait locus 11 9.9
1046 body mass index quantitative trait locus 9 9.9
1047 body mass index quantitative trait locus 8 9.9
1048 body mass index quantitative trait locus 1 9.9
1049 body mass index quantitative trait locus 4 9.9
1050 body mass index quantitative trait locus 10 9.9
1051 body mass index quantitative trait locus 7 9.9
1052 myocardial infarction 9.9
1053 body mass index quantitative trait locus 12 9.9
1054 body mass index quantitative trait locus 14 9.9
1055 body mass index quantitative trait locus 18 9.9
1056 body mass index quantitative trait locus 19 9.9
1057 gastrointestinal ulceration, recurrent, with dysfunctional platelets 9.9
1058 body mass index quantitative trait locus 20 9.9
1059 chlamydia pneumonia 9.9
1060 bone disease 9.9
1061 sarcoma 9.9
1062 esophagitis 9.9
1063 acute leukemia 9.9
1064 ectodermal dysplasia 9.9
1065 sensory peripheral neuropathy 9.9
1066 papilloma 9.9
1067 cystic teratoma 9.9
1068 thymic carcinoma 9.9
1069 temporal lobe epilepsy 9.9
1070 pituitary adenoma 9.9
1071 spindle cell sarcoma 9.9
1072 muscular atrophy 9.9
1073 idiopathic neutropenia 9.9
1074 secondary adrenal insufficiency 9.9
1075 b-cell non-hodgkin lymphoma 9.9
1076 pemphigus erythematosus 9.9
1077 raynaud disease 9.9
1078 homocysteinemia 9.9
1079 orthostatic intolerance 9.9
1080 leukemia, acute lymphoblastic 9.9
1081 beta-thalassemia 9.9
1082 peripartum cardiomyopathy 9.9
1083 leukemia, acute lymphoblastic 3 9.9
1084 sydenham chorea 9.9
1085 cutaneous t cell lymphoma 9.9
1086 gastric ulcer 9.9
1087 q fever 9.9
1088 hydronephrosis 9.9
1089 primary hyperparathyroidism 9.9
1090 hereditary angioedema 9.9
1091 thrombocytosis 9.9
1092 cellulitis 9.9
1093 poliomyelitis 9.9
1094 mature teratoma 9.9
1095 neuroblastoma 9.9
1096 hodgkin's lymphoma, lymphocytic-histiocytic predominance 9.9
1097 back pain 9.9
1098 iga pemphigus 9.9
1099 large granular lymphocyte leukemia 9.9
1100 parathyroid gland disease 9.9 TG INS AIRE
1101 paracoccidioidomycosis 9.9 IL10 IFNG CTLA4
1102 intracranial arteriosclerosis 9.9 TPO INS
1103 fungal meningitis 9.9 IL17A IL10 IFNG
1104 myelopathy, htlv-1-associated 9.9
1105 schistosoma mansoni infection, susceptibility/ 9.9
1106 hemophagocytic lymphohistiocytosis, familial, 1 9.9
1107 systemic lupus erythematosus 3 9.9
1108 neutrophilic dermatosis, acute febrile 9.9
1109 alpha-1-antitrypsin deficiency 9.9
1110 aspergillosis 9.9
1111 retinal dystrophy, iris coloboma, and comedogenic acne syndrome 9.9
1112 metabolic acidosis 9.9
1113 benign teratoma 9.9
1114 pyelonephritis 9.9
1115 otosclerosis 9.9
1116 facial paralysis 9.9
1117 motor neuron disease 9.9
1118 macrocytic anemia 9.9
1119 retinal vascular disease 9.9
1120 psychotic disorder 9.9
1121 ischemia 9.9
1122 gastric adenocarcinoma 9.9
1123 anovulation 9.9
1124 thrombophlebitis 9.9
1125 bronchitis 9.9
1126 pathologic nystagmus 9.9
1127 haemophilus influenzae 9.9
1128 htlv-1 associated myelopathy/tropical spastic paraparesis 9.9
1129 spastic paraparesis 9.9
1130 stevens-johnson syndrome/toxic epidermal necrolysis 9.9
1131 cryptogenic cirrhosis 9.9
1132 hypoxia 9.9
1133 paraneoplastic limbic encephalitis 9.9
1134 secondary interstitial lung disease in childhood and adulthood associated with a connective tissue disease 9.9
1135 fixed drug eruption 9.9
1136 refractory celiac disease 9.9
1137 neonatal lupus erythematosus 9.9
1138 argyria 9.9
1139 infectious encephalitis 9.9
1140 acute adrenal insufficiency 9.9
1141 primary systemic mycosis 9.9 IL17A IL10 IFNG
1142 type 1 diabetes mellitus 12 9.9 PTPRN PTPN22 INS CTLA4
1143 annular erythema 9.9
1144 hypertension, essential 9.9
1145 kearns-sayre syndrome 9.9
1146 pituitary adenoma, prolactin-secreting 9.9
1147 multiple sclerosis 2 9.9
1148 microvascular complications of diabetes 3 9.9
1149 microvascular complications of diabetes 4 9.9
1150 microvascular complications of diabetes 6 9.9
1151 microvascular complications of diabetes 7 9.9
1152 adult t-cell leukemia 9.9
1153 mantle cell lymphoma 9.9
1154 peripheral t-cell lymphoma 9.9
1155 c1 inhibitor deficiency 9.9
1156 osteonecrosis 9.9
1157 optic papillitis 9.9
1158 parotitis 9.9
1159 microcephaly 9.9
1160 prostatic hypertrophy 9.9
1161 choroiditis 9.9
1162 hyperandrogenism 9.9
1163 von willebrand's disease 9.9
1164 focal segmental glomerulosclerosis 9.9
1165 exocrine pancreatic insufficiency 9.9
1166 hepatic encephalopathy 9.9
1167 squamous cell papilloma 9.9
1168 sick building syndrome 9.9
1169 plasmacytoma 9.9
1170 bile duct disease 9.9
1171 hypertrichosis 9.9
1172 dermatophytosis 9.9
1173 lichen planus pemphigoides 9.9
1174 spondylarthropathy 9.9
1175 streptococcal group a invasive disease 9.9
1176 anti-p200 pemphigoid 9.9
1177 overgrowth syndrome 9.9
1178 coccidiosis 9.9 IL17A IL10 IFNG
1179 paranasal sinus disease 9.9 IL17A IL10 IFNG
1180 primary peritoneal carcinoma 9.9 IL10 IFNG
1181 commensal bacterial infectious disease 9.8 IL17A IL10 IFNG
1182 complement component 4, partial deficiency of 9.8
1183 diabetes mellitus, insulin-dependent, 2 9.8
1184 erythermalgia, primary 9.8
1185 attention deficit-hyperactivity disorder 9.8
1186 ataxia-telangiectasia 9.8
1187 fibrosclerosis, multifocal 9.8
1188 hemolytic uremic syndrome, atypical 1 9.8
1189 moyamoya disease 1 9.8
1190 sudden infant death syndrome 9.8
1191 frontotemporal dementia 9.8
1192 cd4/cd8 t-cell ratio 9.8
1193 anorexia nervosa 9.8
1194 lung cancer susceptibility 3 9.8
1195 sexual disorder 9.8
1196 cryptococcal meningitis 9.8
1197 mastitis 9.8
1198 premature menopause 9.8
1199 onchocerciasis 9.8
1200 hidradenitis 9.8
1201 kidney cancer 9.8
1202 gingivitis 9.8
1203 ovarian cyst 9.8
1204 aortitis 9.8
1205 axonal neuropathy 9.8
1206 polycythemia 9.8
1207 babesiosis 9.8
1208 toxoplasmosis 9.8
1209 human t-cell leukemia virus type 1 9.8
1210 monogenic diabetes 9.8
1211 precocious puberty 9.8
1212 gastroesophageal reflux 9.8
1213 gilles de la tourette syndrome 9.8
1214 multiple system atrophy 1 9.8
1215 papillomatosis, confluent and reticulated 9.8
1216 testicular torsion 9.8
1217 volvulus of midgut 9.8
1218 3-methylglutaconic aciduria, type iii 9.8
1219 polycythemia vera 9.8
1220 agammaglobulinemia, x-linked 9.8
1221 graves disease 2 9.8
1222 bulimia nervosa 9.8
1223 major depressive disorder 9.8
1224 esophagitis, eosinophilic, 1 9.8
1225 dengue virus 9.8
1226 t-cell large granular lymphocyte leukemia 9.8
1227 zollinger-ellison syndrome 9.8
1228 infective endocarditis 9.8
1229 collagenous colitis 9.8
1230 glucocorticoid-induced osteoporosis 9.8
1231 drug allergy 9.8
1232 rabies 9.8
1233 alcoholic hepatitis 9.8
1234 leiomyoma 9.8
1235 hypersensitivity reaction type iii disease 9.8
1236 duodenal ulcer 9.8
1237 squamous cell carcinoma 9.8
1238 hidradenitis suppurativa 9.8
1239 protein s deficiency 9.8
1240 empty sella syndrome 9.8
1241 heart valve disease 9.8
1242 seminoma 9.8
1243 bile duct cancer 9.8
1244 epidermolysis bullosa dystrophica 9.8
1245 human immunodeficiency virus infectious disease 9.8
1246 impetigo 9.8
1247 smallpox 9.8
1248 erythema infectiosum 9.8
1249 rosacea 9.8
1250 learning disability 9.8
1251 aphthous stomatitis 9.8
1252 interstitial keratitis 9.8
1253 lymphosarcoma 9.8
1254 paraneoplastic neurologic disorders 9.8
1255 post-transplant lymphoproliferative disease 9.8
1256 thrombasthenia 9.8
1257 wallerian degeneration 9.8
1258 periodic paralysis 9.8
1259 igg4-related thyroid disease 9.8
1260 adenohypophysitis 9.8
1261 sporotrichosis 9.8 IL10 IFNG
1262 burkitt lymphoma 9.8
1263 carpal tunnel syndrome 9.8
1264 seizures, benign familial neonatal, 1 9.8
1265 melanoma, uveal 9.8
1266 neurofibromatosis, type iv, of riccardi 9.8
1267 noonan syndrome 1 9.8
1268 pancreatitis, hereditary 9.8
1269 prostate cancer 9.8
1270 thrombocytopenia 2 9.8
1271 lipoid congenital adrenal hyperplasia 9.8
1272 congenital heart defects, hamartomas of tongue, and polysyndactyly 9.8
1273 lambert syndrome 9.8
1274 gallbladder disease 1 9.8
1275 langerhans cell histiocytosis 9.8
1276 gastrointestinal stromal tumor 9.8
1277 variola major 9.8
1278 hemorrhagic cystitis 9.8
1279 ileitis 9.8
1280 multicentric castleman disease 9.8
1281 osteomyelitis 9.8
1282 cholelithiasis 9.8
1283 pleurisy 9.8
1284 protein-losing enteropathy 9.8
1285 hemiplegia 9.8
1286 microcytic anemia 9.8
1287 cardiac tamponade 9.8
1288 listeriosis 9.8
1289 portal vein thrombosis 9.8
1290 dysgammaglobulinemia 9.8
1291 dengue disease 9.8
1292 intermediate uveitis 9.8
1293 megaloblastic anemia 9.8
1294 benign paroxysmal positional nystagmus 9.8
1295 poems syndrome 9.8
1296 iritis 9.8
1297 autosomal dominant cerebellar ataxia 9.8
1298 keratosis 9.8
1299 ichthyosis 9.8
1300 thyroid gland cancer 9.8
1301 hyperuricemia 9.8
1302 focal epilepsy 9.8
1303 leptospirosis 9.8
1304 glycogen storage disease 9.8
1305 long qt syndrome 9.8
1306 hemoglobinopathy 9.8
1307 glioblastoma multiforme 9.8
1308 fibrosarcoma 9.8
1309 hypokalemia 9.8
1310 anti-basement membrane glomerulonephritis 9.8
1311 cll/sll 9.8
1312 prion disease 9.8
1313 eating disorder 9.8
1314 rem sleep behavior disorder 9.8
1315 postpartum depression 9.8
1316 ankrd26-related thrombocytopenia 9.8
1317 angioimmunoblastic lymphadenopathy with dysproteinemia 9.8
1318 congenital rubella 9.8
1319 cerebrofacial arteriovenous metameric syndrome 9.8
1320 acute sensory ataxic neuropathy 9.8
1321 recurrent acute pancreatitis 9.8
1322 type ii mixed cryoglobulinemia 9.8
1323 pediatric systemic lupus erythematosus 9.8
1324 thyroid tumor 9.8
1325 esophageal cancer 9.7
1326 b-cell growth factor 9.7
1327 alcohol dependence 9.7
1328 periodic fever, familial, autosomal dominant 9.7
1329 huntington disease 9.7
1330 kabuki syndrome 1 9.7
1331 thyroid carcinoma, familial medullary 9.7
1332 neutrophil migration 9.7
1333 thrombocytopenia 3 9.7
1334 pendred syndrome 9.7
1335 amelogenesis imperfecta, type ie 9.7
1336 prostatic hyperplasia, benign 9.7
1337 juvenile myelomonocytic leukemia 9.7
1338 chilblain lupus 1 9.7
1339 acute promyelocytic leukemia 9.7
1340 fatty liver disease, nonalcoholic 1 9.7
1341 leptin deficiency or dysfunction 9.7
1342 helix syndrome 9.7
1343 angina pectoris 9.7
1344 peyronie's disease 9.7
1345 secretory diarrhea 9.7
1346 anaplastic large cell lymphoma 9.7
1347 inflammatory myofibroblastic tumor 9.7
1348 good syndrome 9.7
1349 atrial fibrillation 9.7
1350 mucositis 9.7
1351 postural orthostatic tachycardia syndrome 9.7
1352 thyroid lymphoma 9.7
1353 mooren's ulcer 9.7
1354 salivary gland disease 9.7
1355 lepromatous leprosy 9.7
1356 erysipelas 9.7
1357 coronary artery anomaly 9.7
1358 conn's syndrome 9.7
1359 neurogenic bladder 9.7
1360 bell's palsy 9.7
1361 quadriplegia 9.7
1362 paronychia 9.7
1363 pulmonary sarcoidosis 9.7
1364 essential thrombocythemia 9.7
1365 myeloproliferative neoplasm 9.7
1366 euthyroid sick syndrome 9.7
1367 prostatic adenoma 9.7
1368 central nervous system lymphoma 9.7
1369 plague 9.7
1370 lactic acidosis 9.7
1371 intestinal pseudo-obstruction 9.7
1372 thyroid gland medullary carcinoma 9.7
1373 pseudohypoparathyroidism 9.7
1374 granulomatous dermatitis 9.7
1375 folliculitis 9.7
1376 ureteral obstruction 9.7
1377 gastrinoma 9.7
1378 adenosine deaminase deficiency 9.7
1379 paraplegia 9.7
1380 extrinsic allergic alveolitis 9.7
1381 duodenitis 9.7
1382 vascular dementia 9.7
1383 intermediate coronary syndrome 9.7
1384 yellow fever 9.7
1385 hypersensitivity vasculitis 9.7
1386 bap1 tumor predisposition syndrome 9.7
1387 anti-pit-1 antibody syndrome 9.7
1388 banti's syndrome 9.7
1389 catastrophic antiphospholipid syndrome 9.7
1390 drug reaction with eosinophilia and systemic symptoms 9.7
1391 enteropathy-associated t-cell lymphoma 9.7
1392 hemorrhagic proctocolitis 9.7
1393 progressive encephalomyelitis with rigidity and myoclonus 9.7
1394 pseudobulbar affect 9.7
1395 rohhad 9.7
1396 scleromyxedema 9.7
1397 cerebral atrophy 9.7
1398 pituitary tumors 9.7
1399 pouchitis 9.7
1400 ring chromosome 9.7
1401 secondary pulmonary alveolar proteinosis 9.7
1402 diffuse alveolar hemorrhage 9.7
1403 premature aging 9.7
1404 lymphoepithelioma-like thymic carcinoma 9.7 TG FOXP3
1405 arteries, anomalies of 9.7
1406 blau syndrome 9.7
1407 trigeminal neuralgia 9.7
1408 acth deficiency, isolated 9.7
1409 endocardial fibroelastosis 9.7
1410 hydrops fetalis, nonimmune 9.7
1411 subacute sclerosing panencephalitis 9.7
1412 periodontitis, chronic 9.7
1413 fragile x syndrome 9.7
1414 diabetes mellitus, insulin-dependent, 5 9.7
1415 acute insulin response 9.7
1416 diabetes mellitus, insulin-dependent, 6 9.7
1417 sickle cell anemia 9.7
1418 systemic lupus erythematosus 8 9.7
1419 systemic lupus erythematosus 13 9.7
1420 human herpesvirus 8 9.7
1421 alacrima, achalasia, and mental retardation syndrome 9.7
1422 pachyonychia congenita 3 9.7
1423 glucocorticoid resistance, generalized 9.7
1424 hyperlipoproteinemia, type iii 9.7
1425 bacterial sepsis 9.7
1426 chikungunya 9.7
1427 cryptogenic organizing pneumonia 9.7
1428 female breast cancer 9.7
1429 microscopic colitis 9.7
1430 inguinal hernia 9.7
1431 zika fever 9.7
1432 pollen allergy 9.7
1433 lymphoblastic lymphoma 9.7
1434 pneumoconiosis 9.7
1435 asbestosis 9.7
1436 anthracosis 9.7
1437 prolymphocytic leukemia 9.7
1438 common cold 9.7
1439 microinvasive gastric cancer 9.7
1440 lipoid nephrosis 9.7
1441 cauda equina syndrome 9.7
1442 neonatal diabetes mellitus 9.7
1443 splenic sequestration 9.7
1444 dengue hemorrhagic fever 9.7
1445 tinea pedis 9.7
1446 secondary hyperparathyroidism 9.7
1447 cerebral atherosclerosis 9.7
1448 hellp syndrome 9.7
1449 neurosarcoidosis 9.7
1450 urethritis 9.7
1451 anterior scleritis 9.7
1452 acute poststreptococcal glomerulonephritis 9.7
1453 adult dermatomyositis 9.7
1454 acute cholangitis 9.7
1455 dermatomycosis 9.7
1456 hypoglycemic coma 9.7
1457 mononeuritis multiplex 9.7
1458 impotence 9.7
1459 dental caries 9.7
1460 factor xiii deficiency 9.7
1461 blood platelet disease 9.7
1462 ankylosis 9.7
1463 colon adenocarcinoma 9.7
1464 benign mesothelioma 9.7
1465 testicular cancer 9.7
1466 proctitis 9.7
1467 germinoma 9.7
1468 breast adenocarcinoma 9.7
1469 breast disease 9.7
1470 merkel cell carcinoma 9.7
1471 polyradiculopathy 9.7
1472 dyslexia 9.7
1473 gastric neuroendocrine neoplasm 9.7
1474 calciphylaxis 9.7
1475 mesangial proliferative glomerulonephritis 9.7
1476 borna disease 9.7
1477 colonic disease 9.7
1478 plasma cell neoplasm 9.7
1479 septic arthritis 9.7
1480 bacterial pneumonia 9.7
1481 skin melanoma 9.7
1482 ritter's disease 9.7
1483 scotoma 9.7
1484 epididymo-orchitis 9.7
1485 ulcerative stomatitis 9.7
1486 mitochondrial disorders 9.7
1487 was-related disorders 9.7
1488 al amyloidosis 9.7
1489 carcinoid syndrome 9.7
1490 diffuse cutaneous systemic sclerosis 9.7
1491 dwarfism 9.7
1492 febrile infection-related epilepsy syndrome 9.7
1493 infectious myocarditis 9.7
1494 lymphomatoid granulomatosis 9.7
1495 new-onset refractory status epilepticus 9.7
1496 nodding syndrome 9.7
1497 persistent genital arousal disorder 9.7
1498 primary agammaglobulinemia 9.7
1499 primary central nervous system lymphoma 9.7
1500 pseudo-turner syndrome 9.7
1501 pustular psoriasis 9.7
1502 ring chromosome 18 9.7
1503 hypersomnia 9.7
1504 hypotonia 9.7
1505 myotonia 9.7
1506 asbestos intoxication 9.7
1507 acute transverse myelitis 9.7
1508 secondary hemophagocytic lymphohistiocytosis 9.7
1509 phacoanaphylactic uveitis 9.7
1510 primary anetoderma 9.7
1511 igg4-related kidney disease 9.7
1512 secondary vasculitis 9.7
1513 secondary sclerosing cholangitis 9.7
1514 isolated optic neuritis 9.7
1515 pemphigus vegetans 9.7
1516 refractory cytopenia with multilineage dysplasia 9.7
1517 acute motor axonal neuropathy 9.7
1518 opportunistic mycosis 9.7 IL17A IL10 IFNG AIRE
1519 fascioliasis 9.6 INS IL10 IFNG
1520 diabetes insipidus, nephrogenic, autosomal 9.6
1521 erythroleukemia, familial 9.6
1522 hypercarotenemia and vitamin a deficiency, autosomal dominant 9.6
1523 cardiac arrhythmia 9.6
1524 blood group--kell system 9.6
1525 amelogenesis imperfecta, type ib 9.6
1526 endosteal hyperostosis, autosomal dominant 9.6
1527 pelvic organ prolapse 9.6
1528 exfoliation syndrome 9.6
1529 psoriasis 1 9.6
1530 retinoblastoma 9.6
1531 spondyloepimetaphyseal dysplasia, strudwick type 9.6
1532 strabismus 9.6
1533 thrombophilia due to activated protein c resistance 9.6
1534 suppressor of tumorigenicity 3 9.6
1535 arterial calcification, generalized, of infancy, 1 9.6
1536 australia antigen 9.6
1537 chondrodysplasia punctata syndrome 9.6
1538 cryptorchidism, unilateral or bilateral 9.6
1539 factor v deficiency 9.6
1540 hemochromatosis, neonatal 9.6
1541 bernard-soulier syndrome 9.6
1542 intracranial hypertension, idiopathic 9.6
1543 acetylation, slow 9.6
1544 chylomicron retention disease 9.6
1545 smith-lemli-opitz syndrome 9.6
1546 wilson disease 9.6
1547 adrenoleukodystrophy 9.6
1548 albinism-deafness syndrome 9.6
1549 cyclic vomiting syndrome 9.6
1550 mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes 9.6
1551 diabetes mellitus, insulin-dependent, 4 9.6
1552 supranuclear palsy, progressive, 1 9.6
1553 suppression of tumorigenicity 12 9.6
1554 diabetes mellitus, insulin-dependent, 12 9.6
1555 hemophagocytic lymphohistiocytosis, familial, 2 9.6
1556 cervical cancer 9.6
1557 hypertension, early-onset, autosomal dominant, with severe exacerbation in pregnancy 9.6
1558 cataract 26, multiple types 9.6
1559 diamond-blackfan anemia 2 9.6
1560 myasthenia gravis with thymus hyperplasia 9.6
1561 nasopharyngeal carcinoma 9.6
1562 tubulointerstitial nephritis with uveitis 9.6
1563 endometrial cancer 9.6
1564 systemic lupus erythematosus 4 9.6
1565 celiac disease 3 9.6
1566 west nile virus 9.6
1567 retinal cone dystrophy 4 9.6
1568 thrombocytopenia 4 9.6
1569 myd88 deficiency 9.6
1570 neurodegeneration due to cerebral folate transport deficiency 9.6
1571 muscle hypertrophy 9.6
1572 carbonic anhydrase va deficiency, hyperammonemia due to 9.6
1573 mulchandani-bhoj-conlin syndrome 9.6
1574 hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome 9.6
1575 chronic ulcer of skin 9.6
1576 peripheral vascular disease 9.6
1577 dengue shock syndrome 9.6
1578 tick-borne encephalitis 9.6
1579 intestinal schistosomiasis 9.6
1580 primary cutaneous amyloidosis 9.6
1581 electroclinical syndrome 9.6
1582 lymphoplasmacytic lymphoma 9.6
1583 cd40 ligand deficiency 9.6
1584 pervasive developmental disorder 9.6
1585 heavy chain disease 9.6
1586 cardiac arrest 9.6
1587 purpura fulminans 9.6
1588 cytomegalovirus retinitis 9.6
1589 hyper ige syndrome 9.6
1590 familial cold autoinflammatory syndrome 9.6
1591 asymptomatic neurosyphilis 9.6
1592 sleeping sickness 9.6
1593 trypanosomiasis 9.6
1594 corneal disease 9.6
1595 siderosis 9.6
1596 viral pneumonia 9.6
1597 osteomalacia 9.6
1598 leukodystrophy 9.6
1599 fanconi syndrome 9.6
1600 wolfram syndrome 9.6
1601 renal hypertension 9.6
1602 chronic pyelonephritis 9.6
1603 alport syndrome 9.6
1604 keratomalacia 9.6
1605 pulmonary edema 9.6
1606 constrictive pericarditis 9.6
1607 diabetic autonomic neuropathy 9.6
1608 varicocele 9.6
1609 tolosa-hunt syndrome 9.6
1610 cardiovascular system disease 9.6
1611 megaesophagus 9.6
1612 coccidioidomycosis 9.6
1613 beriberi 9.6
1614 plasmodium falciparum malaria 9.6
1615 bacteriuria 9.6
1616 azoospermia 9.6
1617 suppurative cholangitis 9.6
1618 pyuria 9.6
1619 papilledema 9.6
1620 pleural disease 9.6
1621 arthus reaction 9.6
1622 heart septal defect 9.6
1623 neuroendocrine carcinoma 9.6
1624 intestinal perforation 9.6
1625 transient arthritis 9.6
1626 transient cerebral ischemia 9.6
1627 nocardiosis 9.6
1628 neonatal jaundice 9.6
1629 acromegaly 9.6
1630 testicular disease 9.6
1631 splenic infarction 9.6
1632 hemangioma 9.6
1633 cerebellar disease 9.6
1634 glucosephosphate dehydrogenase deficiency 9.6
1635 newcastle disease 9.6
1636 severe acute respiratory syndrome 9.6
1637 substance abuse 9.6
1638 astrocytoma 9.6
1639 rhabdomyosarcoma 9.6
1640 mammary paget's disease 9.6
1641 choriocarcinoma 9.6
1642 mutism 9.6
1643 familial retinoblastoma 9.6
1644 uremia 9.6
1645 endophthalmitis 9.6
1646 urinary tract obstruction 9.6
1647 von economo's disease 9.6
1648 blepharospasm 9.6
1649 gingival hypertrophy 9.6
1650 scrapie 9.6
1651 overnutrition 9.6
1652 mitochondrial metabolism disease 9.6
1653 intestinal obstruction 9.6
1654 night blindness 9.6
1655 malignant histiocytosis 9.6
1656 in situ carcinoma 9.6
1657 hepatopulmonary syndrome 9.6
1658 gas gangrene 9.6
1659 speech disorder 9.6
1660 intrinsic asthma 9.6
1661 acute myocardial infarction 9.6
1662 blepharitis 9.6
1663 intracranial hypertension 9.6
1664 chronic cholangitis 9.6
1665 sheehan syndrome 9.6
1666 latent syphilis 9.6
1667 periodontosis 9.6
1668 limb-girdle muscular dystrophy 9.6
1669 myotonic dystrophy 9.6
1670 47, xxy 9.6
1671 chronic intestinal pseudoobstruction 9.6
1672 cold urticaria 9.6
1673 cramp-fasciculation syndrome 9.6
1674 cytochrome p450 2d6 variant 9.6
1675 cytomegalic inclusion disease 9.6
1676 diabetic mastopathy 9.6
1677 grover's disease 9.6
1678 lymphangiectasis 9.6
1679 mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes 9.6
1680 myelodysplastic syndrome with excess blasts 9.6
1681 oral cancer 9.6
1682 rheumatoid vasculitis 9.6
1683 sutton disease 2 9.6
1684 thyrotoxic periodic paralysis 9.6
1685 central precocious puberty 9.6
1686 multiple endocrine neoplasia 9.6
1687 foot drop 9.6
1688 chronic cutaneous lupus erythematosus 9.6
1689 t-cell non-hodgkin lymphoma 9.6
1690 immune complex mediated vasculitis 9.6
1691 herpetiform pemphigus 9.6
1692 infundibulo-neurohypophysitis 9.6
1693 igg4-related mesenteritis 9.6
1694 idiopathic anterior uveitis 9.6
1695 bronchiolitis obliterans with obstructive pulmonary disease 9.6
1696 postpartum psychosis 9.6
1697 familial chilblain lupus 9.6
1698 granulomatous mastitis 9.6
1699 bullous impetigo 9.6
1700 obsolete: bullous systemic lupus erythematosus 9.6
1701 complications after hematopoietic stem cell transplantation 9.6
1702 panhypophysitis 9.6
1703 vitreoretinopathy 9.6
1704 rare pulmonary disease 9.6
1705 buruli ulcer 9.6 IL10 IFNG
1706 glucose metabolism disease 9.6 PTPRN INS IL10 GAD2
1707 primary thrombocytopenia 9.6 TNFSF13B IL10 FOXP3
1708 x-linked recessive disease 9.6 IL10 FOXP3 CTLA4
1709 cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 9.5
1710 diabetes insipidus, neurohypophyseal 9.5
1711 glaucoma, primary open angle 9.5
1712 gray platelet syndrome 9.5
1713 leukocyte adhesion deficiency, type i 9.5
1714 angioedema, hereditary, type i 9.5
1715 amyloidosis, primary localized cutaneous, 1 9.5
1716 adie pupil 9.5
1717 hirschsprung disease 1 9.5
1718 leiomyoma, uterine 9.5
1719 leukocyte antigen group five 9.5
1720 chromosome 5q deletion syndrome 9.5
1721 progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 1 9.5
1722 cowden syndrome 1 9.5
1723 myoclonus and ataxia 9.5
1724 nephrolithiasis, calcium oxalate 9.5
1725 hypokalemic periodic paralysis, type 1 9.5
1726 pheochromocytoma 9.5
1727 pityriasis rubra pilaris 9.5
1728 mccune-albright syndrome 9.5
1729 tetralogy of fallot 9.5
1730 thyroid hormone resistance, generalized, autosomal dominant 9.5
1731 torticollis 9.5
1732 muckle-wells syndrome 9.5
1733 vasculopathy, retinal, with cerebral leukodystrophy 9.5
1734 adrenocortical carcinoma, hereditary 9.5
1735 chondrosarcoma 9.5
1736 polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 9.5
1737 fanconi anemia, complementation group a 9.5
1738 galactorrhea 9.5
1739 glycogen storage disease ia 9.5
1740 halo nevi 9.5
1741 halothane hepatitis 9.5
1742 hydrocephalus, congenital, 1 9.5
1743 hypogonadism, male 9.5
1744 schimke immunoosseous dysplasia 9.5
1745 nephrotic syndrome, type 1 9.5
1746 oculocerebral syndrome with hypopigmentation 9.5
1747 nonarteritic anterior ischemic optic neuropathy 9.5
1748 shwachman-diamond syndrome 1 9.5
1749 intrinsic factor deficiency 9.5
1750 scott syndrome 9.5
1751 pseudoxanthoma elasticum 9.5
1752 inflammatory bowel disease 1 9.5
1753 glanzmann thrombasthenia 9.5
1754 graves disease x-linked 1 9.5
1755 allan-herndon-dudley syndrome 9.5
1756 arts syndrome 9.5
1757 muscular dystrophy, duchenne type 9.5
1758 rett syndrome 9.5
1759 retinitis pigmentosa-deafness syndrome 9.5
1760 retinitis pigmentosa 11 9.5
1761 diabetes mellitus, insulin-dependent, 3 9.5
1762 diabetes mellitus, insulin-dependent, 7 9.5
1763 maturity-onset diabetes of the young, type 3 9.5
1764 budd-chiari syndrome 9.5
1765 hyperferritinemia with or without cataract 9.5
1766 nephrotic syndrome, type 2 9.5
1767 chromosome 18q deletion syndrome 9.5
1768 psoriasis 2 9.5
1769 psoriasis 6 9.5
1770 diabetes mellitus, insulin-dependent, 18 9.5
1771 neurodegeneration with brain iron accumulation 3 9.5
1772 meningioma, radiation-induced 9.5
1773 spermatogenic failure 3 9.5
1774 meningioma, familial 9.5
1775 celiac disease 5 9.5
1776 frontotemporal lobar degeneration with tdp43 inclusions, grn-related 9.5
1777 ovarian hyperstimulation syndrome 9.5
1778 tropical calcific pancreatitis 9.5
1779 progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 2 9.5
1780 progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 3 9.5
1781 complement component 5 deficiency 9.5
1782 systemic lupus erythematosus 5 9.5
1783 progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 4 9.5
1784 systemic lupus erythematosus 12 9.5
1785 thrombophilia due to protein s deficiency, autosomal dominant 9.5
1786 breast-ovarian cancer, familial 2 9.5
1787 adiponectin, serum level of, quantitative trait locus 1 9.5
1788 noonan syndrome 6 9.5
1789 encephalopathy, progressive, with or without lipodystrophy 9.5
1790 chronic atrial and intestinal dysrhythmia 9.5
1791 hyperproinsulinemia 9.5
1792 mucopolysaccharidosis-plus syndrome 9.5
1793 fetal akinesia deformation sequence 2 9.5
1794 speech and communication disorders 9.5
1795 adrenal cortical carcinoma 9.5
1796 angiosarcoma 9.5
1797 invasive aspergillosis 9.5
1798 aspiration pneumonia 9.5
1799 arrhythmogenic right ventricular cardiomyopathy 9.5
1800 usher syndrome 9.5
1801 hypochromic microcytic anemia 9.5
1802 peripheral artery disease 9.5
1803 oral squamous cell carcinoma 9.5
1804 large cell neuroendocrine carcinoma 9.5
1805 adrenal gland pheochromocytoma 9.5
1806 mucosal melanoma 9.5
1807 alexithymia 9.5
1808 x-linked chondrodysplasia punctata 1 9.5
1809 penicillin allergy 9.5
1810 hyperekplexia 9.5
1811 salmonellosis 9.5
1812 progressive familial intrahepatic cholestasis 9.5
1813 muscular disease 9.5
1814 fibrous dysplasia 9.5
1815 chronic eosinophilic leukemia 9.5
1816 endometritis 9.5
1817 keratoconus 9.5
1818 dry eye syndrome 9.5
1819 viral meningitis 9.5
1820 berylliosis 9.5
1821 caplan's syndrome 9.5
1822 chronic leukemia 9.5
1823 hypopyon 9.5
1824 gastric lymphoma 9.5
1825 charcot-marie-tooth disease 9.5
1826 open-angle glaucoma 9.5
1827 malignant hypertension 9.5
1828 hydrocephalus 9.5
1829 tooth disease 9.5
1830 corneal edema 9.5
1831 social phobia 9.5
1832 spinal meningioma 9.5
1833 corneal neovascularization 9.5
1834 fissured tongue 9.5
1835 chondrocalcinosis 9.5
1836 diabetic angiopathy 9.5
1837 hepatorenal syndrome 9.5
1838 myopia 9.5
1839 coronary thrombosis 9.5
1840 mononeuropathy 9.5
1841 tympanosclerosis 9.5
1842 tinea corporis 9.5
1843 bronchopneumonia 9.5
1844 chronic progressive external ophthalmoplegia 9.5
1845 nephrocalcinosis 9.5
1846 locked-in syndrome 9.5
1847 shipyard eye 9.5
1848 severe pre-eclampsia 9.5
1849 acute proliferative glomerulonephritis 9.5
1850 typhoid fever 9.5
1851 intestinal tuberculosis 9.5
1852 tuberous sclerosis 9.5
1853 sick sinus syndrome 9.5
1854 alcoholic liver cirrhosis 9.5
1855 blackwater fever 9.5
1856 pericholangitis 9.5
1857 renovascular hypertension 9.5
1858 endogenous depression 9.5
1859 chronic cystitis 9.5
1860 islet cell tumor 9.5
1861 atrial heart septal defect 9.5
1862 gaucher's disease 9.5
1863 trichomoniasis 9.5
1864 leiomyosarcoma 9.5
1865 cerebral palsy 9.5
1866 neuroma 9.5
1867 hyperostosis 9.5
1868 post-traumatic stress disorder 9.5
1869 ovarian lymphoma 9.5
1870 hemorrhagic disease 9.5
1871 granulomatous hepatitis 9.5
1872 craniosynostosis 9.5
1873 monoclonal paraproteinemia 9.5
1874 gangliocytoma 9.5
1875 hematologic cancer 9.5
1876 larynx cancer 9.5
1877 transitional cell carcinoma 9.5
1878 endometrial adenocarcinoma 9.5
1879 breast ductal carcinoma 9.5
1880 granulomatous orchitis 9.5
1881 gallbladder cancer 9.5
1882 lipomatosis 9.5
1883 progressive muscular atrophy 9.5
1884 junctional epidermolysis bullosa 9.5
1885 lysosomal storage disease 9.5
1886 tracheal stenosis 9.5
1887 palmoplantar keratosis 9.5
1888 laryngitis 9.5
1889 necrobiosis lipoidica 9.5
1890 mastocytosis 9.5
1891 pleural empyema 9.5
1892 cranial nerve palsy 9.5
1893 craniopharyngioma 9.5
1894 placental insufficiency 9.5
1895 adrenal cortical adenocarcinoma 9.5
1896 eosinophilic gastritis 9.5
1897 lymphocytic gastritis 9.5
1898 secondary syphilis 9.5
1899 erdheim-chester disease 9.5
1900 peanut allergy 9.5
1901 pleomorphic adenoma 9.5
1902 hypotrichosis 9.5
1903 dysgraphia 9.5
1904 secretory meningioma 9.5
1905 lymphoplasmacyte-rich meningioma 9.5
1906 cervical adenitis 9.5
1907 somatoform disorder 9.5
1908 ganglioneuroma 9.5
1909 tubular adenocarcinoma 9.5
1910 functioning pituitary adenoma 9.5
1911 mediastinal cancer 9.5
1912 salpingitis 9.5
1913 eosinophilic pneumonia 9.5
1914 panic disorder 9.5
1915 acute stress disorder 9.5
1916 lung lymphoma 9.5
1917 compartment syndrome 9.5
1918 mitochondrial myopathy 9.5
1919 active peptic ulcer disease 9.5
1920 parathyroid adenoma 9.5
1921 duodenal gastrinoma 9.5
1922 cocaine abuse 9.5
1923 chronic rhinitis 9.5
1924 scabies 9.5
1925 actinomycosis 9.5
1926 mucormycosis 9.5
1927 seborrheic dermatitis 9.5
1928 molluscum contagiosum 9.5
1929 pityriasis rosea 9.5
1930 sideroblastic anemia 9.5
1931 degenerative disc disease 9.5
1932 liver inflammatory pseudotumor 9.5
1933 amebiasis 9.5
1934 diabetic macular edema 9.5
1935 ocular hypertension 9.5
1936 orbital disease 9.5
1937 tracheitis 9.5
1938 eustachian tube disease 9.5
1939 biliary tract disease 9.5
1940 refractive error 9.5
1941 miliary tuberculosis 9.5
1942 albinism 9.5
1943 c3 glomerulopathy 9.5
1944 zap70-related combined immunodeficiency 9.5
1945 adrenomyeloneuropathy 9.5
1946 b cell prolymphocytic leukemia 9.5
1947 beryllium disease 9.5
1948 brittle diabetes 9.5
1949 broken heart syndrome 9.5
1950 central congenital hypothyroidism 9.5
1951 central serous chorioretinopathy 9.5
1952 cluster headache 9.5
1953 complement component deficiency 9.5
1954 cutaneous sclerosis 9.5
1955 dense deposit disease 9.5
1956 fibrosing mediastinitis 9.5
1957 gigantomastia 9.5
1958 herpes zoster ophthalmicus 9.5
1959 hypomelanotic disorder 9.5
1960 indolent b cell lymphoma 9.5
1961 leukoplakia 9.5
1962 lewis-sumner syndrome 9.5
1963 lymphoma aids related 9.5
1964 pediatric multiple sclerosis 9.5
1965 pediatric ulcerative colitis 9.5
1966 primary orthostatic hypotension 9.5
1967 prurigo nodularis 9.5
1968 stenotrophomonas maltophilia infection 9.5
1969 t-cell prolymphocytic leukemia 9.5
1970 t-cell/histiocyte rich large b cell lymphoma 9.5
1971 vernal keratoconjunctivitis 9.5
1972 zap-70 deficiency 9.5
1973 age-related hearing loss 9.5
1974 head injury 9.5
1975 hereditary neuropathies 9.5
1976 postinfectious encephalomyelitis 9.5
1977 swallowing disorders 9.5
1978 non-paraneoplastic limbic encephalitis 9.5
1979 immuno-osseous dysplasia 9.5
1980 acquired neutropenia 9.5
1981 glycogen storage disease due to glucose-6-phosphatase deficiency 9.5
1982 primary pulmonary lymphoma 9.5
1983 paroxysmal dyskinesia 9.5
1984 chronic beryllium disease 9.5
1985 rare hemorrhagic disorder 9.5
1986 pulmonary arterial hypertension associated with portal hypertension 9.5
1987 specific language disorder 9.5
1988 mid-dermal elastolysis 9.5
1989 hereditary periodic fever syndrome 9.5
1990 idiopathic nephrotic syndrome 9.5
1991 pre-descemet corneal dystrophy 9.5
1992 familial intrahepatic cholestasis 9.5
1993 euthyroid graves orbitopathy 9.5
1994 pneumococcal meningitis 9.5
1995 rare sleep disorder 9.5
1996 lichen amyloidosis 9.5
1997 superficial pemphigus 9.5
1998 non-functioning pituitary adenoma 9.5
1999 hyperpigmentation of the skin 9.5
2000 inherited epidermolysis bullosa 9.5
2001 cardiogenic shock 9.5
2002 acquired lipodystrophy 9.5
2003 precursor t-cell acute lymphoblastic leukemia 9.5
2004 extrinsic cardiomyopathy 9.5 IL17A IL10 FOXP3 CTLA4
2005 allergic conjunctivitis 9.5 IL10 IFNG FOXP3
2006 hair disease 9.4 INS IL17A IL10 CTLA4 AIRE
2007 leukemia, chronic lymphocytic 2 9.4
2008 candidiasis, familial, 1 9.4
2009 carcinoid tumors, intestinal 9.4
2010 cirrhosis, familial 9.4
2011 coronary artery dissection, spontaneous 9.4
2012 danubian endemic familial nephropathy 9.4
2013 optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy 9.4
2014 maturity-onset diabetes of the young, type 1 9.4
2015 maturity-onset diabetes of the young, type 2 9.4
2016 multiple endocrine neoplasia, type i 9.4
2017 enolase, sperm specific 9.4
2018 fanconi renotubular syndrome 1 9.4
2019 familial cold autoinflammatory syndrome 1 9.4
2020 cleft palate, isolated 9.4
2021 cardiomyopathy, dilated, 1a 9.4
2022 progressive familial heart block, type ia 9.4
2023 aortic valve disease 1 9.4
2024 pseudohypoparathyroidism, type ia 9.4
2025 acrocephalopolysyndactyly type iii 9.4
2026 hair whorl 9.4
2027 gilbert syndrome 9.4
2028 hypercalcemia, infantile, 1 9.4
2029 hyperimmunoglobulin g1 syndrome 9.4
2030 hypogonadotropic hypogonadism 7 with or without anosmia 9.4
2031 chromosome 18p deletion syndrome 9.4
2032 kleine-levin hibernation syndrome 9.4
2033 legg-calve-perthes disease 9.4
2034 leukemia, acute monocytic 9.4
2035 lichen planus, familial 9.4
2036 li-fraumeni syndrome 9.4
2037 macroglobulinemia, waldenstrom 1 9.4
2038 macroglossia 9.4
2039 medulloblastoma 9.4
2040 melkersson-rosenthal syndrome 9.4
2041 mesothelioma, malignant 9.4
2042 moebius syndrome 9.4
2043 antigen defined by monoclonal antibody aj9 9.4
2044 episodic ataxia, type 1 9.4
2045 neuropathy, hereditary, with liability to pressure palsies 9.4
2046 cyclic neutropenia 9.4
2047 nevus, epidermal 9.4
2048 schimmelpenning-feuerstein-mims syndrome 9.4
2049 night blindness, congenital stationary, autosomal dominant 2 9.4
2050 optic atrophy 1 9.4
2051 osseous heteroplasia, progressive 9.4